PEGASYSTEMS INC, 10-Q filed on 21 Oct 25
v3.25.3
Cover - shares
9 Months Ended
Sep. 30, 2025
Oct. 14, 2025
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2025  
Document Transition Report false  
Entity File Number 1-11859  
Entity Registrant Name PEGASYSTEMS INC.  
Entity Incorporation, State or Country Code MA  
Entity Tax Identification Number 04-2787865  
Entity Address, Address Line One 225 Wyman Street  
Entity Address, City or Town Waltham  
Entity Address, State or Province MA  
Entity Address, Postal Zip Code 02451  
City Area Code 617  
Local Phone Number 374-9600  
Title of 12(b) Security Common Stock, $.01 par value per share  
Trading Symbol PEGA  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   169,722,783
Amendment Flag false  
Entity Central Index Key 0001013857  
Document Fiscal Year Focus 2025  
Document Fiscal Period Focus Q3  
Current Fiscal Year End Date --12-31  
v3.25.3
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 148,699 $ 337,103
Marketable securities 202,663 402,870
Total cash, cash equivalents, and marketable securities 351,362 739,973
Accounts receivable, net 160,919 305,468
Unbilled receivables, net 175,732 173,085
Other current assets 123,791 115,178
Total current assets 811,804 1,333,704
Long-term unbilled receivables, net 105,863 61,407
Goodwill 81,402 81,113
Other long-term assets 293,717 292,049
Total assets 1,292,786 1,768,273
Current liabilities:    
Accounts payable 8,057 6,226
Accrued expenses 51,857 31,544
Accrued compensation and related expenses 111,650 138,042
Deferred revenue 404,757 423,910
Convertible senior notes, net 0 467,470
Other current liabilities 21,131 18,866
Total current liabilities 597,452 1,086,058
Long-term operating lease liabilities 62,402 67,647
Other long-term liabilities 36,102 29,088
Total liabilities 695,956 1,182,793
Commitments and contingencies (Note 17)
Stockholders’ equity:    
Preferred stock, 1,000 shares authorized; none issued 0 0
Common stock, 400,000 shares authorized; 170,545 and 172,224 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively 1,705 1,722
Additional paid-in capital 370,018 526,102
Retained earnings 233,925 87,901
Accumulated other comprehensive (loss) (8,818) (30,245)
Total stockholders’ equity 596,830 585,480
Total liabilities and stockholders’ equity $ 1,292,786 $ 1,768,273
v3.25.3
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - shares
Sep. 30, 2025
Dec. 31, 2024
Stockholders’ equity:    
Preferred stock, shares authorized (in shares) 1,000,000 1,000,000
Preferred stock, shares issued (in shares) 0 0
Common stock, shares authorized (in shares) 400,000,000 400,000,000
Common stock, shares issued (in shares) 170,545,000 172,224,000
Common stock, shares outstanding (in shares) 170,545,000 172,224,000
v3.25.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenue        
Total revenue $ 381,350 $ 325,050 $ 1,241,495 $ 1,006,350
Cost of revenue        
Total cost of revenue 105,893 96,706 317,917 288,310
Gross profit 275,457 228,344 923,578 718,040
Operating expenses        
Selling and marketing 140,129 127,669 425,329 395,125
Research and development 78,756 74,157 231,826 221,695
General and administrative 42,108 35,694 107,724 84,641
Litigation settlement, net of recoveries 0 0 0 32,403
Restructuring (5) 2,485 (38) 3,283
Total operating expenses 260,988 240,005 764,841 737,147
Income (loss) from operations 14,469 (11,661) 158,737 (19,107)
Foreign currency transaction gain (loss) 7,154 (4,405) (12,179) (7,230)
Interest income 2,660 6,769 11,243 18,835
Interest expense (144) (1,639) (1,172) (5,047)
(Loss) on capped call transactions 0 (689) (223) (667)
Other (loss) income, net (43) 0 19,247 1,684
Income (loss) before (benefit from) provision for income taxes 24,096 (11,625) 175,653 (11,532)
(Benefit from) provision for income taxes (19,268) 2,765 16,790 8,369
Net income (loss) $ 43,364 $ (14,390) $ 158,863 $ (19,901)
Earnings (loss) per share        
Basic (in dollars per share) $ 0.25 $ (0.08) $ 0.93 $ (0.12)
Diluted (in dollars per share) $ 0.24 $ (0.08) $ 0.86 $ (0.12)
Weighted-average number of common shares outstanding        
Basic (in shares) 170,567 171,250 171,045 170,036
Diluted (in shares) 184,095 171,250 185,005 170,036
Subscription services        
Revenue        
Total revenue $ 264,198 $ 224,810 $ 737,703 $ 651,143
Cost of revenue        
Total cost of revenue 42,978 36,868 122,616 108,930
Subscription license        
Revenue        
Total revenue 60,600 45,420 327,118 193,405
Cost of revenue        
Total cost of revenue 314 384 1,060 1,504
Consulting        
Revenue        
Total revenue 56,394 54,364 174,639 160,451
Cost of revenue        
Total cost of revenue 62,601 59,451 194,235 177,864
Perpetual license        
Revenue        
Total revenue 158 456 2,035 1,351
Cost of revenue        
Total cost of revenue $ 0 $ 3 $ 6 $ 12
v3.25.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Statement of Comprehensive Income [Abstract]        
Net income (loss) $ 43,364 $ (14,390) $ 158,863 $ (19,901)
Other comprehensive (loss) income, net of tax        
Unrealized gain (loss) on available-for-sale securities 89 660 11 (158)
Foreign currency translation adjustments (4,595) 10,204 21,416 4,635
Total other comprehensive (loss) income, net of tax (4,506) 10,864 21,427 4,477
Comprehensive income (loss) $ 38,858 $ (3,526) $ 180,290 $ (15,424)
v3.25.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional paid-in capital
Retained earnings
Accumulated other comprehensive (loss)
Balance, beginning of period (in shares) at Dec. 31, 2023   167,680      
Balance, beginning of period at Dec. 31, 2023 $ 353,838 $ 1,676 $ 378,746 $ (8,705) $ (17,879)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for stock compensation plans (in shares)   2,278      
Issuance of common stock for stock compensation plans 18,656 $ 23 18,633    
Issuance of common stock under the employee stock purchase plan (in shares)   64      
Issuance of common stock under the employee stock purchase plan 1,758 $ 1 1,757    
Stock-based compensation 34,781   34,781    
Cash dividends declared (2,550)   (2,550)    
Other comprehensive income (loss) (4,173)       (4,173)
Net income (loss) (12,124)     (12,124)  
Balance, end of period (in shares) at Mar. 31, 2024   170,022      
Balance, end of period at Mar. 31, 2024 390,186 $ 1,700 431,367 (20,829) (22,052)
Balance, beginning of period (in shares) at Dec. 31, 2023   167,680      
Balance, beginning of period at Dec. 31, 2023 353,838 $ 1,676 378,746 (8,705) (17,879)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Other comprehensive income (loss) 4,477        
Net income (loss) (19,901)        
Balance, end of period (in shares) at Sep. 30, 2024   171,616      
Balance, end of period at Sep. 30, 2024 473,023 $ 1,716 513,315 (28,606) (13,402)
Balance, beginning of period (in shares) at Mar. 31, 2024   170,022      
Balance, beginning of period at Mar. 31, 2024 390,186 $ 1,700 431,367 (20,829) (22,052)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for stock compensation plans (in shares)   652      
Issuance of common stock for stock compensation plans 5,485 $ 7 5,478    
Issuance of common stock under the employee stock purchase plan (in shares)   64      
Issuance of common stock under the employee stock purchase plan 1,669 $ 1 1,668    
Stock-based compensation 36,224   36,224    
Cash dividends declared (2,561)   (2,561)    
Other comprehensive income (loss) (2,214)       (2,214)
Net income (loss) 6,613     6,613  
Balance, end of period (in shares) at Jun. 30, 2024   170,738      
Balance, end of period at Jun. 30, 2024 435,402 $ 1,708 472,176 (14,216) (24,266)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Repurchase of common stock (in shares)   (342)      
Repurchase of common stock (11,749) $ (3) (11,746)    
Issuance of common stock for stock compensation plans (in shares)   1,162      
Issuance of common stock for stock compensation plans 16,467 $ 11 16,456    
Issuance of common stock under the employee stock purchase plan (in shares)   58      
Issuance of common stock under the employee stock purchase plan 1,789   1,789    
Stock-based compensation 37,213   37,213    
Cash dividends declared (2,573)   (2,573)    
Other comprehensive income (loss) 10,864       10,864
Net income (loss) (14,390)     (14,390)  
Balance, end of period (in shares) at Sep. 30, 2024   171,616      
Balance, end of period at Sep. 30, 2024 $ 473,023 $ 1,716 513,315 (28,606) (13,402)
Balance, beginning of period (in shares) at Dec. 31, 2024 172,224 172,224      
Balance, beginning of period at Dec. 31, 2024 $ 585,480 $ 1,722 526,102 87,901 (30,245)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Repurchase of common stock (in shares)   (2,920)      
Repurchase of common stock (118,704) $ (30) (118,674)    
Issuance of common stock for stock compensation plans (in shares)   1,756      
Issuance of common stock for stock compensation plans 9,754 $ 18 9,736    
Issuance of common stock under the employee stock purchase plan (in shares)   64      
Issuance of common stock under the employee stock purchase plan 1,911 $ 2 1,909    
Stock-based compensation 41,425   41,425    
Cash dividends declared (2,567)     (2,567)  
Other comprehensive income (loss) 8,548       8,548
Net income (loss) 85,422     85,422  
Balance, end of period (in shares) at Mar. 31, 2025   171,124      
Balance, end of period at Mar. 31, 2025 $ 611,269 $ 1,712 460,498 170,756 (21,697)
Balance, beginning of period (in shares) at Dec. 31, 2024 172,224 172,224      
Balance, beginning of period at Dec. 31, 2024 $ 585,480 $ 1,722 526,102 87,901 (30,245)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Repurchase of common stock (in shares) (8,700)        
Repurchase of common stock $ (393,200)        
Other comprehensive income (loss) 21,427        
Net income (loss) $ 158,863        
Balance, end of period (in shares) at Sep. 30, 2025 170,545 170,545      
Balance, end of period at Sep. 30, 2025 $ 596,830 $ 1,705 370,018 233,925 (8,818)
Balance, beginning of period (in shares) at Mar. 31, 2025   171,124      
Balance, beginning of period at Mar. 31, 2025 611,269 $ 1,712 460,498 170,756 (21,697)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Repurchase of common stock (in shares)   (3,147)      
Repurchase of common stock (132,485) $ (31) (132,454)    
Issuance of common stock for stock compensation plans (in shares)   3,086      
Issuance of common stock for stock compensation plans 64,906 $ 30 64,876    
Issuance of common stock under the employee stock purchase plan (in shares)   39      
Issuance of common stock under the employee stock purchase plan 1,816   1,816    
Stock-based compensation 36,730   36,730    
Cash dividends declared (5,156)     (5,156)  
Other comprehensive income (loss) 17,385       17,385
Net income (loss) 30,077     30,077  
Balance, end of period (in shares) at Jun. 30, 2025   171,102      
Balance, end of period at Jun. 30, 2025 624,542 $ 1,711 431,466 195,677 (4,312)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Repurchase of common stock (in shares)   (2,675)      
Repurchase of common stock (142,576) $ (27) (142,549)    
Issuance of common stock for stock compensation plans (in shares)   2,078      
Issuance of common stock for stock compensation plans 36,103 $ 21 36,082    
Issuance of common stock under the employee stock purchase plan (in shares)   40      
Issuance of common stock under the employee stock purchase plan 1,978   1,978    
Stock-based compensation 43,041   43,041    
Cash dividends declared (5,116)     (5,116)  
Other comprehensive income (loss) (4,506)       (4,506)
Net income (loss) $ 43,364     43,364  
Balance, end of period (in shares) at Sep. 30, 2025 170,545 170,545      
Balance, end of period at Sep. 30, 2025 $ 596,830 $ 1,705 $ 370,018 $ 233,925 $ (8,818)
v3.25.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) - $ / shares
3 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Statement of Stockholders' Equity [Abstract]            
Cash dividends declared (in dollars per share) $ 0.03 $ 0.03 $ 0.015 $ 0.015 $ 0.015 $ 0.015
v3.25.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Operating activities        
Net income (loss) $ 43,364 $ (14,390) $ 158,863 $ (19,901)
Adjustments to reconcile net income (loss) to cash provided by operating activities        
Stock-based compensation 43,041 37,213 121,196 108,218
Amortization of deferred commissions 16,916 14,867 50,494 47,143
Amortization of intangible assets and depreciation     9,414 13,289
Amortization of right-of-use lease assets     8,988 13,748
Foreign currency transaction loss (7,154) 4,405 12,179 7,230
Loss on capped call transactions 0 689 223 667
Deferred income taxes     235 (67)
(Accretion) of investments     (2,574) (10,944)
(Gain) on investments     (19,438) (1,628)
Other non-cash     1,526 2,380
Change in operating assets and liabilities, net     5,690 90,562
Cash provided by operating activities     346,796 250,697
Investing activities        
Purchases of investments     (238,956) (417,310)
Proceeds from maturities and called investments     362,436 206,232
Sales of investments     99,902 0
Investment in property and equipment     (8,485) (4,921)
Cash provided by (used in) investing activities     214,897 (215,999)
Financing activities        
Repurchases of convertible senior notes     (467,864) 0
Dividend payments to stockholders     (10,306) (7,626)
Proceeds from employee stock plans     129,112 48,811
Common stock repurchases for tax withholdings for net settlement of equity awards     (12,644) (2,987)
Common stock repurchases under stock repurchase program     (394,689) (11,249)
Cash (used in) provided by financing activities     (756,391) 26,949
Effect of exchange rate changes on cash, cash equivalents, and restricted cash     6,971 4,591
Net (decrease) increase in cash, cash equivalents, and restricted cash     (187,727) 66,238
Cash, cash equivalents, and restricted cash, beginning of period     341,529 232,827
Cash, cash equivalents, and restricted cash, end of period 153,802 299,065 153,802 299,065
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract]        
Cash and cash equivalents 148,699 287,649 148,699 287,649
Restricted cash included in other current assets 0 184 0 184
Restricted cash included in other long-term assets 5,103 11,232 5,103 11,232
Total cash, cash equivalents, and restricted cash $ 153,802 $ 299,065 $ 153,802 $ 299,065
v3.25.3
BASIS OF PRESENTATION
9 Months Ended
Sep. 30, 2025
Accounting Policies [Abstract]  
BASIS OF PRESENTATION
NOTE 1. BASIS OF PRESENTATION
Pegasystems Inc. (together with its subsidiaries, “the Company”) has prepared the accompanying unaudited condensed consolidated financial statements pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Accordingly, they do not include all the information required by the generally accepted accounting principles (“GAAP”) in the United States of America (“U.S.”) for complete financial statements and should be read in conjunction with the Company’s audited financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2024.
In the opinion of management, the Company has prepared the accompanying unaudited condensed consolidated financial statements on the same basis as its audited financial statements, and these financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results of the interim periods presented.
All intercompany transactions and balances were eliminated in consolidation. The operating results for the interim periods presented do not necessarily indicate the expected results for fiscal year 2025.
Stock Split
On February 12, 2025, the Company’s Board of Directors approved a two-for-one forward stock split (the “Stock Split”) of the Company’s common stock, par value $0.01 (“Common Stock”), to be effected as a stock dividend and a proportionate increase in the number of authorized shares of Common Stock from 200,000,000 to 400,000,000 (the “Authorized Share Increase”). The Authorized Share Increase was subject to shareholder approval of an amendment to the Company’s Restated Articles of Organization. The requisite shareholder approval was obtained on June 17, 2025. On June 20, 2025, each shareholder of record at the close of business on June 10, 2025 (the “Record Date”) received one additional share of Common Stock for each share of Common Stock held on the Record Date. All share, per share, and equity award information in the Company’s unaudited condensed consolidated financial statements and in the accompanying notes for all periods presented have been recast to reflect the effect of the Stock Split. The shares of Common Stock retained a par value of $0.01 per share. Accordingly, an amount equal to the par value of the increased shares resulting from the Stock Split was reclassified from additional paid-in capital to common stock.
v3.25.3
NEW ACCOUNTING PRONOUNCEMENTS
9 Months Ended
Sep. 30, 2025
Accounting Policies [Abstract]  
NEW ACCOUNTING PRONOUNCEMENTS
NOTE 2. NEW ACCOUNTING PRONOUNCEMENTS
Improvements to Income Tax Disclosures
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 includes expanded income tax rate reconciliation disclosures, a disaggregation of income taxes paid, and other expanded disclosures. ASU 2023-09 will be effective for the Company for the year ending December 31, 2025. The Company expects the adoption to result in disclosure changes only.
Disaggregation of Income Statement Expenses
In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (ASU “2024-03”). Among other items, the requirements include expanded disclosures around employee compensation and selling expenses. ASU 2024-03 will be effective for the Company for the year ending December 31, 2027. The Company is still evaluating the impact of this new guidance on its consolidated financial statements but expects the adoption to result in disclosure changes only.
v3.25.3
MARKETABLE SECURITIES
9 Months Ended
Sep. 30, 2025
Investments, Debt and Equity Securities [Abstract]  
MARKETABLE SECURITIES
NOTE 3. MARKETABLE SECURITIES
September 30, 2025December 31, 2024
(in thousands)Amortized CostUnrealized GainsUnrealized LossesFair ValueAmortized CostUnrealized GainsUnrealized LossesFair Value
Government debt$10,500 $11 $(8)$10,503 $11,851 $$(19)$11,833 
Corporate debt191,692 561 (93)192,160 391,097 63 (123)391,037 
$202,192 $572 $(101)$202,663 $402,948 $64 $(142)$402,870 
As of September 30, 2025, marketable securities’ maturities ranged from October 2025 to September 2028, with a weighted-average remaining maturity of 1.4 years.
v3.25.3
RECEIVABLES, CONTRACT ASSETS, AND DEFERRED REVENUE
9 Months Ended
Sep. 30, 2025
Receivables [Abstract]  
RECEIVABLES, CONTRACT ASSETS, AND DEFERRED REVENUE
NOTE 4. RECEIVABLES, CONTRACT ASSETS, AND DEFERRED REVENUE
Receivables
(in thousands)
September 30, 2025December 31, 2024
Accounts receivable, net$160,919 $305,468 
Unbilled receivables, net175,732 173,085 
Long-term unbilled receivables, net
105,863 61,407 
$442,514 $539,960 
Unbilled receivables
Unbilled receivables are client-committed amounts for which revenue recognition precedes billing. Billing is solely subject to the passage of time.
Unbilled receivables by expected collection date:
(Dollars in thousands)
September 30, 2025
1 year or less$175,732 62 %
1-2 years63,974 23 %
2-5 years41,889 15 %
$281,595 100 %
Unbilled receivables by contract effective date:
(Dollars in thousands)
September 30, 2025
2025$135,540 48 %
202486,021 31 %
202352,162 19 %
20223,714 %
2021 and prior4,158 %
$281,595 100 %
Major clients
Clients that represented 10% or more of the Company’s total accounts receivable and unbilled receivables:
September 30, 2025December 31, 2024
Client A
Accounts receivable*20 %
Unbilled receivables*— %
Total receivables*11 %
Client B
Accounts receivable— %*
Unbilled receivables18 %*
Total receivables12 %*
*Client accounted for less than 10% of total accounts receivable and unbilled receivables.
Contract assets
Contract assets are client-committed amounts for which revenue recognized exceeds the amount billed to the client, and billing is subject to conditions other than the passage of time, such as the completion of a related performance obligation.
(in thousands)
September 30, 2025December 31, 2024
Contract assets (1)
$22,465 $13,498 
Long-term contract assets (2)
28,588 18,321 
$51,053 $31,819 
(1) Included in other current assets.
(2) Included in other long-term assets.
Deferred revenue
Deferred revenue consists of billings made and payments received in advance of revenue recognition.
(in thousands)
September 30, 2025December 31, 2024
Deferred revenue$404,757 $423,910 
Long-term deferred revenue (1)
2,457 2,121 
$407,214 $426,031 
(1) Included in other long-term liabilities.
The change in deferred revenue during the nine months ended September 30, 2025 was primarily due to new billings in advance of revenue recognition and $384 million of revenue recognized during the period included in deferred revenue as of December 31, 2024.
v3.25.3
DEFERRED COMMISSIONS
9 Months Ended
Sep. 30, 2025
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
DEFERRED COMMISSIONS
NOTE 5. DEFERRED COMMISSIONS
(in thousands)
September 30, 2025December 31, 2024
Deferred commissions (1)
$99,423 $105,405 
(1) Included in other long-term assets.
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in thousands)2025202420252024
Amortization of deferred commissions (1)
$16,916 $14,867 $50,494 $47,143 
(1) Included in selling and marketing expenses.
v3.25.3
GOODWILL AND OTHER INTANGIBLES
9 Months Ended
Sep. 30, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND OTHER INTANGIBLES
NOTE 6. GOODWILL AND OTHER INTANGIBLES
Goodwill
Nine Months Ended
September 30,
(in thousands)
20252024
January 1,$81,113 $81,611 
Currency translation adjustments289 (43)
September 30,$81,402 $81,568 
Intangibles
Intangible assets are recorded at cost and amortized using the straight-line method over their estimated useful lives.
September 30, 2025
(in thousands)Useful LivesCostAccumulated Amortization
Net Book Value (1)
Client-related
4-10 years
$63,161 $(62,476)$685 
Technology
2-10 years
68,115 (66,971)1,144 
Other
1-5 years
5,361 (5,361)— 
$136,637 $(134,808)$1,829 
(1) Included in other long-term assets.
December 31, 2024
(in thousands)Useful LivesCostAccumulated Amortization
Net Book Value (1)
Client-related
4-10 years
$63,107 $(61,395)$1,712 
Technology
2-10 years
68,115 (65,995)2,120 
Other
1-5 years
5,361 (5,361)— 
$136,583 $(132,751)$3,832 
(1) Included in other long-term assets.
Future estimated amortization of intangible assets:
(in thousands)September 30, 2025
Remainder of 2025$627 
2026874 
2027328 
$1,829 
Amortization of intangible assets:
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in thousands)2025202420252024
Cost of revenue
$284 $357 $975 $1,425 
Selling and marketing
343 343 1,028 1,028 
$627 $700 $2,003 $2,453 
v3.25.3
OTHER ASSETS AND LIABILITIES
9 Months Ended
Sep. 30, 2025
Other Assets and Liabilities [Abstract]  
OTHER ASSETS AND LIABILITIES
NOTE 7. OTHER ASSETS AND LIABILITIES
Other current assets
(in thousands)September 30, 2025December 31, 2024
Prepaid expenses$39,970 $38,155 
Income tax receivables56,332 58,359 
Contract assets22,465 13,498 
Indirect tax receivable1,954 2,488 
Capped call transactions— 223 
Restricted cash— 98 
Other3,070 2,357 
$123,791 $115,178 
Other long-term assets
(in thousands)September 30, 2025December 31, 2024
Deferred commissions$99,423 $105,405 
Right of use assets59,397 62,429 
Property and equipment43,036 41,806 
Venture investments20,214 21,234 
Contract assets28,588 18,321 
Income taxes receivable14,270 13,299 
Intangible assets1,829 3,832 
Deferred income taxes3,973 4,268 
Restricted cash5,103 4,328 
Other17,884 17,127 
$293,717 $292,049 
Accrued expenses
(in thousands)September 30, 2025December 31, 2024
Cloud hosting$16,445 $1,802 
Outside professional services18,187 10,639 
Marketing and sales program1,472 2,150 
Income and other taxes4,653 5,055 
Employee related5,692 4,833 
Repurchases of common stock unsettled— 1,500 
Other5,408 5,565 
$51,857 $31,544 
Other current liabilities
(in thousands)September 30, 2025December 31, 2024
Operating lease liabilities$14,424 $14,551 
Dividends payable5,116 2,583 
Other1,591 1,732 
$21,131 $18,866 
Other long-term liabilities
(in thousands)September 30, 2025December 31, 2024
Deferred revenue$2,457 $2,121 
Income taxes payable20,983 15,956 
Other12,662 11,011 
$36,102 $29,088 
v3.25.3
SEGMENT INFORMATION
9 Months Ended
Sep. 30, 2025
Segment Reporting [Abstract]  
SEGMENT INFORMATION
NOTE 8. SEGMENT INFORMATION
Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision-maker (“CODM”) in deciding how to allocate resources and assess performance.
The Company derives substantially all of its revenue from the sale and support of one group of similar products and services – software that provides case management, business process management, and real-time decisioning solutions to improve customer engagement and operational excellence in the enterprise applications market. To assess performance, the Company’s CODM, the Chief Executive Officer, reviews financial information on a consolidated basis. Therefore, the Company determined it has one operating segment and one reportable segment. The accounting policies of the Company’s operating segment are the same as those described in "Note 2. Significant Accounting Policies" included in the Annual Report on Form 10-K for the year ended December 31, 2024. The CODM uses consolidated net income (loss) to set financial performance targets, assess performance, and make expense allocation decisions.
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in thousands)2025202420252024
Total revenue$381,350 $325,050 $1,241,495 $1,006,350 
Total cost of revenue105,893 96,706 317,917 288,310 
Selling
119,764 109,952 354,932 331,915 
Marketing
20,365 17,717 70,397 63,210 
Research and development78,756 74,157 231,826 221,695 
General and administrative42,108 35,694 107,724 84,641 
Other segment items, net (1)
(9,632)2,449 (16,954)28,111 
(Benefit from) provision for income taxes(19,268)2,765 16,790 8,369 
Net income (loss)$43,364 $(14,390)$158,863 $(19,901)
(1) Includes Litigation settlement, net of recoveries, Restructuring, Foreign currency transaction gain (loss), Interest income, Interest expense, (Loss) on capped call transactions, and Other (loss) income, net.

Long-lived assets related to the Company’s U.S. and international operations consist of property and equipment, which are included in Other long-term assets in the Company’s consolidated balance sheet:
(in thousands)
September 30, 2025December 31, 2024
U.S.$37,433 87 %$37,405 89 %
International5,603 13 %4,401 11 %
$43,036 100 %$41,806 100 %
v3.25.3
LEASES
9 Months Ended
Sep. 30, 2025
Leases [Abstract]  
LEASES
NOTE 9. LEASES
On January 1, 2025, the Company relocated its corporate headquarters to 225 Wyman Street, Waltham, Massachusetts.
Expense
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in thousands)2025202420252024
Fixed lease costs$4,128 $6,848 $11,828 $16,381 
Short-term lease costs420 381 1,330 1,334 
Variable lease costs1,351 1,863 4,909 5,235 
$5,899 $9,092 $18,067 $22,950 
Right of use assets and lease liabilities
(in thousands)September 30, 2025December 31, 2024
Right of use assets (1)
$59,397 $62,429 
Operating lease liabilities (2)
$14,424 $14,551 
Long-term operating lease liabilities$62,402 $67,647 
(1) Included in other long-term assets.
(2) Included in other current liabilities.
Weighted-average remaining lease term and discount rate for the Company’s leases were:
September 30, 2025December 31, 2024
Weighted-average remaining lease term5.7 years6.2 years
Weighted-average discount rate (1)
4.9 %4.8 %
(1) The rates implicit in the Company’s leases are not readily determinable. Therefore, the Company uses its incremental borrowing rate as the discount rate when measuring operating lease liabilities. The incremental borrowing rate represents an estimate of the interest rate the Company would incur to borrow an amount equal to the lease payments on a collateralized basis over the lease term in a similar economic environment.
Maturities of lease liabilities:
(in thousands)September 30, 2025
Remainder of 2025$4,615 
202616,971 
202715,494 
202814,357 
202911,343 
20309,754 
Thereafter15,411 
Total lease payments87,945 
Less: imputed interest (1)
(11,119)
$76,826 
(1) Lease liabilities are measured at the present value of the remaining lease payments using a discount rate determined at lease commencement unless the discount rate is updated due to a lease reassessment event.
Cash flow information
Nine Months Ended
September 30,
(in thousands)20252024
Cash paid for operating leases, net of tenant improvement allowances$14,502 $13,249 
Right of use assets recognized for new leases and amendments (non-cash)$4,765 $12,290 
v3.25.3
DEBT
9 Months Ended
Sep. 30, 2025
Debt Disclosure [Abstract]  
DEBT
NOTE 10. DEBT
Convertible senior notes and capped calls
Convertible senior notes
In February 2020, the Company issued Convertible Senior Notes (the "Notes") with an aggregate principal of $600 million, due March 1, 2025, in a private placement. No principal payments were due before maturity. The Notes accrued interest at an annual rate of 0.75%, paid semi-annually in arrears on March 1 and September 1, beginning September 1, 2020. The remaining outstanding principal balance on the Notes and accrued interest totaling $469.6 million was repaid in its entirety at maturity during the three months ended March 31, 2025.
Conversion rights
The conversion rate was 14.809 shares of Common stock per $1,000 principal amount of the Notes, representing an initial conversion price of $67.53 per share of Common stock.
Carrying value of the Notes:
(in thousands)September 30, 2025December 31, 2024
Principal$— $467,864 
Unamortized issuance costs— (394)
Convertible senior notes, net$— $467,470 

Interest expense related to the Notes:
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in thousands)2025202420252024
Contractual interest expense (0.75% coupon)
$— $941 $595 $2,825 
Amortization of issuance costs
— 621 394 1,857 
$— $1,562 $989 $4,682 
The average interest rate on the Notes during the three months ended March 31, 2025 and nine months ended September 30, 2024 was 1.2%.
Capped call transactions
In February 2020, the Company entered into privately negotiated capped call transactions (the “Capped Call Transactions”) with certain financial institutions. The Capped Call Transactions initially covered approximately 8.8 million shares (representing the number of shares for which the Notes were initially convertible) of the Company’s Common Stock. As of December 31, 2024, Capped Call Transactions covering approximately 7 million shares were outstanding, and expired upon maturity of the Notes during the three months ended March 31, 2025.
Change in capped call transactions:
Nine Months Ended
September 30,
(in thousands)20252024
January 1,$223 $893 
Fair value adjustment(223)(667)
September 30,$— $226 
Credit facility
In November 2019, and as since amended, the Company entered into a five-year $100 million senior secured revolving credit agreement (the “Credit Facility”) with PNC Bank, National Association. The Company may use borrowings for general corporate purposes and to finance working capital needs. Subject to specific conditions and the agreement of the financial institutions lending the additional amount, the aggregate commitment may be increased to $200 million. The Credit Facility, as amended, contains customary covenants, including, but not limited to, those relating to additional indebtedness, liens, asset divestitures, and affiliate transactions. Beginning with the fiscal quarter ended March 31, 2024, the Company must maintain a maximum net consolidated leverage ratio of 3.5 to 1.0 (with a step-up for certain acquisitions) and a minimum consolidated interest coverage ratio of 3.5 to 1.0. Effective as of February 4, 2025, the Credit Facility was amended to extend the expiration date to February 4, 2027. As of September 30, 2025, the Company is compliant with all Credit Facility covenants.
As of September 30, 2025 and December 31, 2024, the Company had letters of credit of $26.7 million and $27.3 million, respectively, under the Credit Facility, however had no cash borrowings.
v3.25.3
RESTRUCTURING
9 Months Ended
Sep. 30, 2025
Restructuring and Related Activities [Abstract]  
RESTRUCTURING
NOTE 11. RESTRUCTURING
The Company has undertaken the following restructuring activities as it optimizes its go-to-market strategy and reassesses its office space needs:
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in thousands)2025202420252024
Employee severance and related costs
$(11)$(397)$(68)$(634)
Office space reductions (1)
2,882 30 3,917 
      Restructuring
$(5)$2,485 $(38)$3,283 
(1) These primarily relate to non-cash operating lease adjustments.
Restructuring activity:
Accrued employee severance and related costs:
Nine Months Ended
September 30,
(in thousands)20252024
January 1,$2,000 $8,095 
Costs incurred(68)(634)
Cash disbursements(1,681)(4,214)
Currency translation adjustments115 (93)
September 30, (1)
$366 $3,154 
(1) Included in accrued compensation and related expenses.
v3.25.3
FAIR VALUE MEASUREMENTS
9 Months Ended
Sep. 30, 2025
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS
NOTE 12. FAIR VALUE MEASUREMENTS
Assets and liabilities measured at fair value on a recurring basis
The Company records its cash equivalents, marketable securities, capped call transactions, and venture investments at fair value on a recurring basis. Fair value is an exit price, representing the amount that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants based on assumptions that market participants would use in pricing an asset or liability.
As a basis for classifying the fair value measurements, a three-tier fair value hierarchy, which classifies the fair value measurements based on the inputs used in measuring fair value, was established as follows:
Level 1 - observable inputs, such as quoted prices in active markets for identical assets or liabilities;
Level 2 - significant other inputs that are observable either directly or indirectly; and
Level 3 - significant unobservable inputs with little or no market data, which require the Company to develop its own assumptions.
This hierarchy requires the Company to use observable market data when available and minimize unobservable inputs when determining fair value.
The fair value of the Capped Call Transactions at the end of each reporting period is determined using a Black-Scholes option-pricing model. The valuation model uses various market-based inputs, including stock price, remaining contractual term, expected volatility, risk-free interest rate, and expected dividend yield. The Company applied judgment when determining expected volatility. The Company considered the underlying equity security’s historical and implied volatility levels. The Capped Call Transactions expired upon maturity of the Notes during the three months ended March 31, 2025. The Company’s venture investments are recorded at fair value based on multiple valuation methods, including observable public companies and transaction prices and unobservable inputs, including the volatility, rights, and obligations of the securities the Company holds.
Assets and liabilities measured at fair value on a recurring basis:
September 30, 2025December 31, 2024
(in thousands)Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Cash equivalents$8,157 $5,119 $— $13,276 $5,318 $148,926 $— $154,244 
Marketable securities $— $202,663 $— $202,663 $— $402,870 $— $402,870 
Capped Call Transactions
$— $— $— $— $— $223 $— $223 
Venture investments$— $— $20,214 $20,214 $— $— $21,234 $21,234 

Changes in venture investments:
Nine Months Ended
September 30,
(in thousands)20252024
January 1,$21,234 $19,450 
New investments13,129 350 
Sales of investments(33,223)— 
Changes in foreign exchange rates129 106 
Changes in fair value:
included in other (loss) income, net
19,480 1,628 
included in other comprehensive income (loss)
(535)(362)
September 30,$20,214 $21,172 
During the three months ended June 30, 2025, one of the Company’s investees was acquired by a privately held company. As a result, the Company received $33.2 million in consideration for its equity interest in the investee, composed of $22.1 million cash and $11.1 million of an ownership interest in the privately held company, and recognized a $18.7 million gain in excess of cost in other (loss) income, net on the condensed consolidated statements of operations.
The carrying value of certain financial instruments, including receivables and accounts payable, approximates fair value due to their short maturities.
Fair value of the Convertible Senior Notes
The fair value of the Notes outstanding (including the embedded conversion feature) was $463.9 million as of December 31, 2024. The Notes were repaid in full at maturity during the three months ended March 31, 2025.
The fair value was determined based on the Notes’ quoted price in an over-the-counter market on the last trading day of the reporting period and classified within Level 2 in the fair value hierarchy.
v3.25.3
REVENUE
9 Months Ended
Sep. 30, 2025
Revenue from Contract with Customer [Abstract]  
REVENUE
NOTE 13. REVENUE
Geographic revenue
Revenues by geography are determined based on client location:
Three Months Ended
September 30,
Nine Months Ended
September 30,
(Dollars in thousands)
2025202420252024
U.S.$185,132 49 %$156,135 48 %$662,440 54 %$526,332 53 %
Other Americas23,511 %28,836 %76,884 %71,936 %
United Kingdom (“U.K.”)53,099 14 %37,593 12 %134,475 11 %108,338 11 %
Europe (excluding U.K.), Middle East, and Africa 64,410 17 %60,048 18 %202,886 16 %175,255 17 %
Asia-Pacific55,198 14 %42,438 13 %164,810 13 %124,489 12 %
$381,350 100 %$325,050 100 %$1,241,495 100 %$1,006,350 100 %
Revenue streams
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in thousands)
2025202420252024
Pega Cloud$184,549 $144,108 $502,415 $409,096 
Maintenance79,649 80,702 235,288 242,047 
Consulting56,394 54,364 174,639 160,451 
Revenue recognized over time320,592 279,174 912,342 811,594 
Subscription license60,600 45,420 327,118 193,405 
Perpetual license158 456 2,035 1,351 
Revenue recognized at a point in time60,758 45,876 329,153 194,756 
Total revenue$381,350 $325,050 $1,241,495 $1,006,350 
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in thousands)2025202420252024
Pega Cloud$184,549 $144,108 $502,415 $409,096 
Maintenance79,649 80,702 235,288 242,047 
Subscription services264,198 224,810 737,703 651,143 
Subscription license60,600 45,420 327,118 193,405 
Subscription324,798 270,230 1,064,821 844,548 
Consulting56,394 54,364 174,639 160,451 
Perpetual license158 456 2,035 1,351 
Total revenue$381,350 $325,050 $1,241,495 $1,006,350 
Remaining performance obligations ("Backlog")
Expected future revenue from existing non-cancellable contracts:
As of September 30, 2025:
(Dollars in thousands)Subscription servicesSubscription licensePerpetual licenseConsultingTotal
Pega CloudMaintenance
1 year or less
$609,511 $199,651 $46,228 $158 $43,979 $899,527 51 %
1-2 years
319,940 71,730 4,404 — 2,478 398,552 23 %
2-3 years
164,125 48,668 746 — 114 213,653 12 %
Greater than 3 years
195,133 40,385 7,220 — 56 242,794 14 %
$1,288,709 $360,434 $58,598 $158 $46,627 $1,754,526 100 %
As of September 30, 2024:
(Dollars in thousands)Subscription servicesSubscription licensePerpetual licenseConsultingTotal
Pega CloudMaintenance
1 year or less
$495,637 $188,905 $38,175 $2,252 $54,203 $779,172 53 %
1-2 years
310,020 63,701 9,686 317 3,062 386,786 26 %
2-3 years
146,877 26,436 3,046 — 2,008 178,367 12 %
Greater than 3 years
112,002 18,854 102 — — 130,958 %
$1,064,536 $297,896 $51,009 $2,569 $59,273 $1,475,283 100 %
v3.25.3
STOCKHOLDERS' EQUITY
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
STOCKHOLDERS' EQUITY
NOTE 14. STOCKHOLDERS' EQUITY
Stock-based Compensation Expense
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in thousands)2025202420252024
Cost of revenue
$6,626 $6,894 $21,737 $20,558 
Selling and marketing
15,009 14,169 45,168 41,621 
Research and development
7,914 7,308 23,789 22,779 
General and administrative
13,492 8,842 30,502 23,260 
$43,041 $37,213 $121,196 $108,218 
Income tax benefit
$(547)$(512)$(1,700)$(1,377)
As of September 30, 2025, the Company had $129 million of unrecognized stock-based compensation expense, net of estimated forfeitures, which is expected to be recognized over a weighted-average period of 1.8 years.
Grants
Nine Months Ended
September 30, 2025
(in thousands)
Quantity
Total Fair Value
Restricted stock units (1)
2,055$82,098 
Non-qualified stock options
3,296 $53,132 
Performance stock options (2)
1,362 $35,324 
Common stock
18$928 
(1) Includes units issued when employees elect to receive 50% of the employee’s target incentive compensation under the Company’s Corporate Incentive Compensation Plan (the “CICP”) in the form of RSUs instead of cash.
(2) Performance stock options allow the holder to purchase a specified number of Common Stock shares at an exercise price equal to or greater than the shares' fair market value at the grant date. The performance stock options granted in the nine months ended September 30, 2025 vest quarterly over two years, beginning after the achievement of specific performance conditions. The options expire ten years from the grant date.
Stock repurchase program
On April 22, 2025, the Company’s Board of Directors extended the expiration date of the share repurchase program from December 31, 2025 to June 30, 2026 and increased the authorized repurchase amount by $500 million, bringing the total repurchase authorization to $810 million, of which $347.3 million remains available as of September 30, 2025.
During the nine months ended September 30, 2025, the Company repurchased 8.7 million of its common stock for $393.2 million at an average price per share of $44.97. The share repurchase and authorization amounts disclosed within this Form 10-Q exclude the U.S. excise tax on share repurchases. All purchases under this program have been made on the open market.
Stock Split
On June 20, 2025, the Company effected the Stock Split of the Company’s Common Stock described above in “Note 1. Basis of Presentation”. All share and per share amounts in the Company’s unaudited condensed consolidated financial statements and in the accompanying notes for all prior periods presented have been recast to reflect the effect of the Stock Split.
v3.25.3
INCOME TAXES
9 Months Ended
Sep. 30, 2025
Income Tax Disclosure [Abstract]  
INCOME TAXES
NOTE 15. INCOME TAXES
Effective income tax rate
Nine Months Ended
September 30,
(Dollars in thousands)20252024
(Benefit from) provision for income taxes$16,790 $8,369 
Effective income tax rate10 %(73)%
The Company’s effective income tax rate for the nine months ended September 30, 2025, was impacted by excess tax benefits from stock-based compensation, and by the enactment of the One Big Beautiful Bill Act (“OBBBA”) on July 4, 2025. The OBBBA introduced several U.S. tax law changes, including the ability to immediately expense domestic research and experimental (“R&E”) expenditures starting in 2025, and an election to accelerate any unamortized domestic R&E expenditures over a one or two year period beginning with the 2025 tax year. In accordance with ASC 740, Accounting for Income Taxes, the impacts of the OBBBA are reflected in the Company’s results for the quarter ended September 30, 2025. The enactment of the OBBBA reduced the Company’s forecasted U.S. income tax expense for 2025. However, the changes did not affect the Company’s U.S. deferred tax assets or liabilities, as the Company continues to maintain a full valuation allowance against those balances.
The Company recognizes deferred tax assets to the extent that it believes that these assets are more likely than not to be realized. Future realization of deferred tax assets ultimately depends on sufficient taxable income within the available carryback or carryforward periods. The Company’s deferred tax valuation allowance requires significant judgment and has uncertainties, including assumptions about future taxable income based on historical and projected information. In assessing the Company’s ability to realize its net deferred tax assets, the Company considered various factors including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and recent financial results to determine whether it is more likely than not that some portion or all of its net deferred tax assets will not be realized.
The Company intends to maintain a valuation allowance on its U.S. and U.K. net deferred tax assets until positive sufficient evidence exists to support their realization. Given the Company’s recent earnings, the Company believes that there is a reasonable possibility that in a near future period sufficient positive evidence may become available to allow the Company to reach a conclusion that a substantial portion of the valuation allowance will no longer be needed. However, the exact timing and amount of the valuation allowance release are subject to significant judgment. Release of the valuation allowance would result in the recognition of certain deferred tax assets and a decrease to income tax expense for the period the release is recorded.
v3.25.3
EARNINGS (LOSS) PER SHARE
9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
EARNINGS (LOSS) PER SHARE
NOTE 16. EARNINGS (LOSS) PER SHARE
Basic earnings (loss) per share is calculated using the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share is calculated using the weighted-average number of common shares outstanding during the period, plus the dilutive effect of outstanding stock options, RSUs, and Notes.
Calculation of earnings (loss) per share:
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in thousands, except per share amounts) (1)
2025202420252024
Net income (loss)$43,364 $(14,390)$158,863 $(19,901)
Weighted-average common shares outstanding170,567 171,250 171,045 170,036 
Earnings (loss) per share, basic$0.25 $(0.08)$0.93 $(0.12)
Net income (loss)$43,364 $(14,390)$158,863 $(19,901)
Notes - interest expense, net of tax
— — 742 — 
Numerator for diluted EPS $43,364 $(14,390)$159,605 $(19,901)
Weighted-average effect of dilutive securities:
Notes
1,599
Stock options10,1138,971
RSUs3,4153,390
Effect of dilutive securities13,52813,960
Weighted-average common shares outstanding, assuming dilution (2) (3) (4)
184,095171,250185,005170,036
Earnings (loss) per share, diluted$0.24 $(0.08)$0.86 $(0.12)
Outstanding anti-dilutive stock options and RSUs (5)
549,0562677,364
(1) The number of shares and per share amounts have been recast for all prior periods presented to reflect the effect of the Company’s Stock Split effected in the form of a stock dividend distributed on June 20, 2025.
(2) All securities are excluded when their inclusion would be anti-dilutive.
(3) The weighted-average shares underlying the conversion options in the Company’s Notes are included using the if-converted method, if dilutive in the period.
(4) The Company’s Capped Call Transactions represented the equivalent number of shares of the Company’s common stock (representing the number of shares for which the Notes are convertible). The Capped Call Transactions are excluded from weighted-average common shares outstanding, assuming dilution, in all periods as their effect would be anti-dilutive.
(5) Outstanding stock options and RSUs that were anti-dilutive under the treasury stock method in the period were excluded from the computation of diluted earnings (loss) per share. These awards may be dilutive in the future.
v3.25.3
COMMITMENTS AND CONTINGENCIES
9 Months Ended
Sep. 30, 2025
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES
NOTE 17. COMMITMENTS AND CONTINGENCIES
Commitments
See "Note 9. Leases" for additional information.
Legal proceedings
In addition to the matters below, the Company is or may become involved in a variety of claims, demands, suits, investigations, and proceedings that arise from time to time relating to matters incidental to the ordinary course of the Company’s business, including actions concerning contracts, intellectual property, employment, benefits, and securities matters. Regardless of the outcome, legal disputes can have a material effect on the Company because of defense and settlement costs, diversion of management resources, and other factors.
In addition, as the Company is a party to ongoing litigation, it is at least reasonably possible that the Company’s estimates will change in the near term, and the effect may be material. The Company had no accrued losses for litigation for the below matters as of September 30, 2025 and December 31, 2024.
Appian Corp. v. Pegasystems Inc. & Youyong Zou
The Company is a defendant in litigation brought by Appian in the Circuit Court of Fairfax County, Virginia (the “Court”) titled Appian Corp. v. Pegasystems Inc. & Youyong Zou, No. 2020-07216 (Fairfax Cty. Ct.). On May 9, 2022, the jury rendered its verdict finding that the Company had misappropriated one or more of Appian’s trade secrets, that the Company had violated the Virginia Computer Crimes Act, and that the trade secret misappropriation was willful and malicious. The jury awarded damages of $2,036,860,045 for trade secret misappropriation and $1.00 for violating the Virginia Computer Crimes Act. On September 15, 2022, the circuit court of Fairfax County entered judgment of $2,060,479,287, consisting of the damages previously awarded by the jury plus attorneys’ fees and costs, and stating that the judgment is subject to post-judgment interest at a rate of 6.0% per annum, from the date of the jury verdict (May 9, 2022) as to the amount of the jury verdict and from September 15, 2022 as to the amount of the award of attorneys’ fees and costs. On September 15, 2022, the Company filed a notice of appeal from the judgment. On September 29, 2022, the circuit court of Fairfax County approved a $25,000,000 letter of credit obtained by the Company to secure the judgment and entered an order suspending the judgment during the pendency of the Company’s appeal. A panel of the Court of Appeals of Virginia heard oral arguments on November 15, 2023, and issued a written opinion on July 30, 2024. The Court of Appeals reversed the judgment on Appian’s Virginia Uniform Trade Secrets Act claim and ordered a new trial on that claim. Appian filed a petition for appeal with the Supreme Court of Virginia on August 29, 2024, and the Company filed a response to the petition on October 21, 2024. On March 7, 2025, the Supreme Court of Virginia granted Appian’s petition for appeal and Pega’s assignments of cross-error. The parties have completed briefing before the Supreme Court of Virginia. The Supreme Court of Virginia is scheduled to hear oral argument on the parties’ substantive appellate briefs on October 28, 2025. The Company continues to believe that it did not misappropriate any alleged trade secrets and that its sales of the Company’s products at issue were not caused by, or the result of, any alleged misappropriation of trade secrets. The Company is unable to reasonably estimate possible damages because of, among other things, uncertainty as to the outcome of appellate proceedings and/or any potential new trial resulting from the appellate proceedings.
PS Lit Recovery, LLC v. Pegasystems Inc., Alan Trefler, and Kenneth Stillwell and Eminence Fund Long Master, Ltd., Eminence Fund Master, Ltd., Eminence Fund II Master, LP, Eminence Partners Long II, LP, Eminence Fund Leveraged Master, Ltd., Eminence Partners, L.P., Eminence Partners II, L.P. v. Pegasystems Inc., Alan Trefler, and Kenneth Stillwell
On December 4, 2024, the shareholders representing approximately 3% of the settlement class that opted out of the court approved settlement in the class action matter captioned City of Fort Lauderdale Police and Firefighters’ Retirement System, Individually and on Behalf of All Others Similarly Situated v. Pegasystems Inc., Alan Trefler, and Kenneth Stillwell (Case 1:22-cv-00578-LMB-IDD) (the “Class Action”) filed two lawsuits against the Company, the Company’s chief executive officer, and the Company’s chief operating and financial officer in the United States District Court for the District of Massachusetts. The first is captioned Eminence Fund Long Master, Ltd., Eminence Fund Master, Ltd., Eminence Fund II Master, LP, Eminence Partners Long II, LP, Eminence Fund Leveraged Master, Ltd., Eminence Partners, L.P., and Eminence Partners II, L.P. v. Pegasystems Inc., Alan Trefler, and Kenneth Stillwell (Case 1:24-cv-12999-WGY); the second is captioned PS Lit Recovery, LLC v. Pegasystems Inc., Alan Trefler, and Kenneth Stillwell (Case 1:24-cv-11220-WGY). The complaints, which are substantially similar, generally allege, among other things, that the defendants violated Section 10(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, and that the individual defendants violated Section 20(a) of the Exchange Act, in each case by allegedly making materially false and/or misleading statements, as well as allegedly failing to disclose material adverse facts about the Company’s business, operations, and prospects, which caused the Company’s securities to trade at artificially inflated prices. The complaints also assert claims for common law fraud and negligent misrepresentation, and seek unspecified damages. The defendants moved to dismiss the complaints on March 13, 2025. The plaintiffs filed a brief in opposition to the motion to dismiss on April 10, 2025. The defendants filed a reply brief in support of the motion to dismiss on April 10, 2025. On May 21, 2025, the Court held a hearing on the motion to dismiss. At the conclusion of the hearing, the Court (i) granted the motion to dismiss as to the plaintiffs’ scheme liability claims; (ii) granted the motion to dismiss as to all claims against Ken Stillwell, except for the plaintiffs’ control person liability claims; and (iii) took the motion to dismiss under advisement as to all other claims. The parties are awaiting a written order ruling on the motion to dismiss as to the remaining claims.
On February 26, 2025, the same shareholders filed two lawsuits against the Company, the Company’s chief executive officer, and the Company’s chief operating and financial officer in Massachusetts Superior Court. The first is captioned Eminence Fund Long Master, Ltd., Eminence Fund Master, Ltd., Eminence Fund II Master, LP, Eminence Partners Long II, LP, Eminence Fund Leveraged Master, Ltd., Eminence Partners, L.P., and Eminence Partners II, L.P. v. Pegasystems Inc., Alan Trefler, and Kenneth Stillwell (Case No. 2584CV00541-BLS1); the second is captioned PS Lit Recovery, LLC v. Pegasystems, Inc., Alan Trefler, and Kenneth Stillwell (Case No. 2584CV00539-BLS1). The complaints, which are substantially similar, allege the same state law claims raised in the two federal lawsuits brought by the same plaintiffs in the United States District Court for the District of Massachusetts. On April 14, 2025, the court granted the parties’ joint stipulations to stay both cases pending the resolution of the parallel federal actions and ordered the plaintiffs to file periodic status reports regarding the federal cases showing cause why the state cases should remain open.
The Company believes it has strong defenses to the claims brought against the defendants and intends to defend against these claims vigorously. The Company is unable to reasonably estimate possible damages or a range of possible damages in these matters given the stage of the lawsuits.
In re Pegasystems Inc., Derivative Litigation
Federal court cases
On November 21, 2022, a lawsuit was filed against the members of the Company’s board of directors, the Company’s chief operating and financial officer and the Company in the United States District Court for the District of Massachusetts, captioned Mary Larkin, derivatively on behalf of nominal defendant Pegasystems Inc. v. Peter Gyenes, Richard Jones, Christopher Lafond, Dianne Ledingham, Sharon Rowlands, Alan Trefler, Larry Weber, and Kenneth Stillwell, defendants, and Pegasystems Inc., nominal defendant (Case 1:22-cv-11985). On April 28, 2023, a lawsuit was filed in the United States District Court for the District of Massachusetts by Dag Sagfors, derivatively on behalf of nominal defendant Pegasystems Inc., asserting breach of fiduciary duty and related claims relating to the Virginia Appian litigation against the same defendants as the Larkin lawsuit. On May 17, 2023, the Larkin and Sagfors cases were consolidated (the “Consolidated Action”) and, after defendants moved to dismiss the complaint in the Consolidated Action on December 4, 2024, the plaintiffs moved to voluntarily dismiss the Consolidated Action, and the Court granted the motion to dismiss on December 18, 2024.
The Company separately received confidential demand letters raising substantially the same allegations set forth in the Consolidated Action. On April 12, 2023, the Company’s board of directors (other than Mr. Trefler, who recused himself), formed a committee consisting solely of independent directors, to review, analyze, and investigate the matters raised in the demands and to determine in good faith what actions (if any) were reasonably believed to be appropriate under similar circumstances and reasonably believed to be in the best interests of the Company in response to the demand letters (the “Demand Review Committee”). The Demand Review Committee, with the assistance of independent legal counsel, conducted an extensive investigation of the allegations raised in the demand letters and on October 7, 2024 issued a report concluding that there are no valid claims against the Company’s directors and officers with respect to the matters raised in the demands and that it would not be in the Company’s best interests to pursue litigation against them.
On February 7, 2025, the plaintiffs in the Consolidated Action filed a new complaint against the members of the Company’s board of directors, certain employees of the Company, and the Company in the United States District Court for the District of Massachusetts, captioned Mary Larkin and Dag Sagfors, derivatively on behalf of nominal defendant Pegasystems Inc. v. Alan Trefler, Peter Gyenes, Richard Jones, Christopher Lafond, Dianne Ledingham, Sharon Rowlands, Leon Trefler, Larry Weber, Kenneth Stillwell, Don Schuerman, Kerim Akgonul, and Benjamin Baril, (the “Defendants”), and Pegasystems Inc., nominal defendant (Case 1:25-cv-10303). The complaint asserts against Defendants claims for breach of fiduciary duty, unjust enrichment, and violations of the Exchange Act relating to (i) the litigation brought by Appian in the Circuit Court of Fairfax County, Virginia, described above; (ii) alleged misconduct by Company employees alleged in that litigation; and the Class Action, described above. The Defendants filed motions to dismiss the complaint on April 28, 2025. On June 6, 2025, the plaintiffs in the consolidated derivative matter currently pending in Massachusetts Superior Court, Case No. 2484CV01734 (discussed below), moved to intervene in this matter and to stay it pending the resolution of the state derivative matter. The Court held a hearing on defendants’ motions to dismiss and state court plaintiffs’ motion to intervene on July 21, 2025. Following argument, the Court took the motions under advisement.
On October 14, 2025, the parties jointly notified the Court that on October 2, 2025 the Massachusetts Superior Court granted defendants’ motion to dismiss the related state court derivative action (see below) and proposed that the Court refrain from issuing a decision on the motions to dismiss pending a joint submission by the parties of their respective positions on the impact of the state court dismissal on the federal court case within thirty (30) days.
The Company believes it has strong defenses to the claims brought against the defendants and intends to defend against these claims vigorously. The Company is unable to reasonably estimate possible damages or a range of possible damages in these matters given the stage of the lawsuits and there being no specified quantum of damages sought in the complaints.
State court cases
On June 28, 2024, a lawsuit was filed against members of the Company’s board of directors, certain employees of the Company and the Company in the Business Litigation Section of the Superior Court in Suffolk County, Massachusetts, captioned John Dwyer and Ray Gerber, Plaintiffs, v. Alan Trefler, Peter Gyenes, Richard Jones, Christopher Lafond, Dianne Ledingham, Sharon Rowlands, Larry Weber, Leon Trefler, Don Schuerman, Kerim Akgonul, and Benjamin Baril, (“Defendants”), and Pegasystems Inc., Nominal Defendant (Case 2484CV01734) (“Dwyer Action”). The complaint generally alleges the Defendants breached their fiduciary duties in connection with alleged misconduct by Company employees alleged in the litigation brought by Appian in the Circuit Court of Fairfax County, Virginia, described above, and alleges damages from the approximately $2 billion verdict in the litigation brought by Appian in the Circuit Court of Fairfax County, Virginia, described above, the settlement of the Class Action, and litigation costs from various proceedings.
On November 22, 2024, a lawsuit was filed against members of the Company’s board of directors, certain employees of the Company and the Company in the Business Litigation Section of the Superior Court in Suffolk County, Massachusetts, captioned Jayne Birch and Robert Garfield, Plaintiffs, v. Alan Trefler, Peter Gyenes, Richard Jones, Christopher Lafond, Dianne Ledingham, Sharon Rowlands, Larry Weber, Kerim Akgonul, Don Schuerman, Leon Trefler, Douglas Kim, John Petronio, Benjamin Baril, and Kenneth Stillwell, (“Defendants”), and Pegasystems Inc., Nominal Defendant (Case 2484CV03076-BLS-1) (“Birch Action”). The complaint generally asserts the same claims asserted in the Dwyer Action.
On February 12, 2025, after submission by the parties of a stipulation and proposed order, an order was entered consolidating the Dwyer and Birch Actions and approving the schedule for the filing of a consolidated complaint and a motion to dismiss. On March 14, 2025, the plaintiffs filed a consolidated complaint in Case No. 2484CV01734. The consolidated complaint generally alleges the Defendants breached their fiduciary duties in connection with alleged misconduct by Company employees alleged in the litigation brought by Appian in the Circuit Court of Fairfax County, Virginia, described above, and in connection with the investigation conducted and the report issued by the Demand Review Committee of the Company’s board regarding the same. The Defendants moved to dismiss the complaint and after briefing by the parties, the Court held a hearing on defendants’ motion on September 4, 2025. On October 2, 2025, the Court granted Defendants’ motion to dismiss and the parties’ are awaiting entry of a judgment of dismissal.
The Company believes it has strong defenses to the claims brought against the defendants and intends to defend against these claims vigorously. The Company is unable to reasonably estimate possible damages or a range of possible damages in these matters given the stage of the lawsuits.
v3.25.3
Insider Trading Arrangements
shares in Thousands
3 Months Ended
Sep. 30, 2025
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Kenneth Stillwell [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement On August 12, 2025, Kenneth Stillwell, our Chief Operating Officer and Chief Financial Officer, entered into a “Rule 10b5-1 trading arrangement” that provides for the sale of 36,000 shares of our common stock. The arrangement will terminate on December 31, 2026, subject to early termination for certain specified events set forth in the arrangement.
Name Kenneth Stillwell
Title Chief Operating Officer and Chief Financial Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date August 12, 2025
Expiration Date December 31, 2026
Arrangement Duration 506 days
Aggregate Available 36
v3.25.3
NEW ACCOUNTING PRONOUNCEMENTS (Policies)
9 Months Ended
Sep. 30, 2025
Accounting Policies [Abstract]  
Basis of presentation
Pegasystems Inc. (together with its subsidiaries, “the Company”) has prepared the accompanying unaudited condensed consolidated financial statements pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Accordingly, they do not include all the information required by the generally accepted accounting principles (“GAAP”) in the United States of America (“U.S.”) for complete financial statements and should be read in conjunction with the Company’s audited financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2024.
In the opinion of management, the Company has prepared the accompanying unaudited condensed consolidated financial statements on the same basis as its audited financial statements, and these financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results of the interim periods presented.
All intercompany transactions and balances were eliminated in consolidation. The operating results for the interim periods presented do not necessarily indicate the expected results for fiscal year 2025.
New accounting pronouncements
Improvements to Income Tax Disclosures
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 includes expanded income tax rate reconciliation disclosures, a disaggregation of income taxes paid, and other expanded disclosures. ASU 2023-09 will be effective for the Company for the year ending December 31, 2025. The Company expects the adoption to result in disclosure changes only.
Disaggregation of Income Statement Expenses
In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (ASU “2024-03”). Among other items, the requirements include expanded disclosures around employee compensation and selling expenses. ASU 2024-03 will be effective for the Company for the year ending December 31, 2027. The Company is still evaluating the impact of this new guidance on its consolidated financial statements but expects the adoption to result in disclosure changes only
Assets and liabilities measured at fair value on a recurring basis
Assets and liabilities measured at fair value on a recurring basis
The Company records its cash equivalents, marketable securities, capped call transactions, and venture investments at fair value on a recurring basis. Fair value is an exit price, representing the amount that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants based on assumptions that market participants would use in pricing an asset or liability.
As a basis for classifying the fair value measurements, a three-tier fair value hierarchy, which classifies the fair value measurements based on the inputs used in measuring fair value, was established as follows:
Level 1 - observable inputs, such as quoted prices in active markets for identical assets or liabilities;
Level 2 - significant other inputs that are observable either directly or indirectly; and
Level 3 - significant unobservable inputs with little or no market data, which require the Company to develop its own assumptions.
This hierarchy requires the Company to use observable market data when available and minimize unobservable inputs when determining fair value.
The fair value of the Capped Call Transactions at the end of each reporting period is determined using a Black-Scholes option-pricing model. The valuation model uses various market-based inputs, including stock price, remaining contractual term, expected volatility, risk-free interest rate, and expected dividend yield. The Company applied judgment when determining expected volatility. The Company considered the underlying equity security’s historical and implied volatility levels. The Capped Call Transactions expired upon maturity of the Notes during the three months ended March 31, 2025. The Company’s venture investments are recorded at fair value based on multiple valuation methods, including observable public companies and transaction prices and unobservable inputs, including the volatility, rights, and obligations of the securities the Company holds.
v3.25.3
MARKETABLE SECURITIES (Tables)
9 Months Ended
Sep. 30, 2025
Investments, Debt and Equity Securities [Abstract]  
Schedule of Marketable Securities
September 30, 2025December 31, 2024
(in thousands)Amortized CostUnrealized GainsUnrealized LossesFair ValueAmortized CostUnrealized GainsUnrealized LossesFair Value
Government debt$10,500 $11 $(8)$10,503 $11,851 $$(19)$11,833 
Corporate debt191,692 561 (93)192,160 391,097 63 (123)391,037 
$202,192 $572 $(101)$202,663 $402,948 $64 $(142)$402,870 
v3.25.3
RECEIVABLES, CONTRACT ASSETS, AND DEFERRED REVENUE (Tables)
9 Months Ended
Sep. 30, 2025
Receivables [Abstract]  
Schedule of Receivables
Receivables
(in thousands)
September 30, 2025December 31, 2024
Accounts receivable, net$160,919 $305,468 
Unbilled receivables, net175,732 173,085 
Long-term unbilled receivables, net
105,863 61,407 
$442,514 $539,960 
Schedule of Unbilled Receivables
Unbilled receivables by expected collection date:
(Dollars in thousands)
September 30, 2025
1 year or less$175,732 62 %
1-2 years63,974 23 %
2-5 years41,889 15 %
$281,595 100 %
Schedule of Unbilled Receivables by Contract Effective Date
Unbilled receivables by contract effective date:
(Dollars in thousands)
September 30, 2025
2025$135,540 48 %
202486,021 31 %
202352,162 19 %
20223,714 %
2021 and prior4,158 %
$281,595 100 %
Schedule of Total Accounts Receivable and Unbilled Receivables
Clients that represented 10% or more of the Company’s total accounts receivable and unbilled receivables:
September 30, 2025December 31, 2024
Client A
Accounts receivable*20 %
Unbilled receivables*— %
Total receivables*11 %
Client B
Accounts receivable— %*
Unbilled receivables18 %*
Total receivables12 %*
*Client accounted for less than 10% of total accounts receivable and unbilled receivables.
Schedule of Contract Assets and Deferred Revenue
Contract assets
Contract assets are client-committed amounts for which revenue recognized exceeds the amount billed to the client, and billing is subject to conditions other than the passage of time, such as the completion of a related performance obligation.
(in thousands)
September 30, 2025December 31, 2024
Contract assets (1)
$22,465 $13,498 
Long-term contract assets (2)
28,588 18,321 
$51,053 $31,819 
(1) Included in other current assets.
(2) Included in other long-term assets.
Deferred revenue
Deferred revenue consists of billings made and payments received in advance of revenue recognition.
(in thousands)
September 30, 2025December 31, 2024
Deferred revenue$404,757 $423,910 
Long-term deferred revenue (1)
2,457 2,121 
$407,214 $426,031 
(1) Included in other long-term liabilities.
v3.25.3
DEFERRED COMMISSIONS (Tables)
9 Months Ended
Sep. 30, 2025
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Schedule of Impairment of Deferred Commissions
(in thousands)
September 30, 2025December 31, 2024
Deferred commissions (1)
$99,423 $105,405 
(1) Included in other long-term assets.
Schedule of Amortization of Deferred Commissions
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in thousands)2025202420252024
Amortization of deferred commissions (1)
$16,916 $14,867 $50,494 $47,143 
(1) Included in selling and marketing expenses.
v3.25.3
GOODWILL AND OTHER INTANGIBLES (Tables)
9 Months Ended
Sep. 30, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
Nine Months Ended
September 30,
(in thousands)
20252024
January 1,$81,113 $81,611 
Currency translation adjustments289 (43)
September 30,$81,402 $81,568 
Schedule of Intangibles
Intangible assets are recorded at cost and amortized using the straight-line method over their estimated useful lives.
September 30, 2025
(in thousands)Useful LivesCostAccumulated Amortization
Net Book Value (1)
Client-related
4-10 years
$63,161 $(62,476)$685 
Technology
2-10 years
68,115 (66,971)1,144 
Other
1-5 years
5,361 (5,361)— 
$136,637 $(134,808)$1,829 
(1) Included in other long-term assets.
December 31, 2024
(in thousands)Useful LivesCostAccumulated Amortization
Net Book Value (1)
Client-related
4-10 years
$63,107 $(61,395)$1,712 
Technology
2-10 years
68,115 (65,995)2,120 
Other
1-5 years
5,361 (5,361)— 
$136,583 $(132,751)$3,832 
(1) Included in other long-term assets.
Schedule of Future Estimated Amortization of Intangible Assets
Future estimated amortization of intangible assets:
(in thousands)September 30, 2025
Remainder of 2025$627 
2026874 
2027328 
$1,829 
Schedule of Amortization of Intangible Assets
Amortization of intangible assets:
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in thousands)2025202420252024
Cost of revenue
$284 $357 $975 $1,425 
Selling and marketing
343 343 1,028 1,028 
$627 $700 $2,003 $2,453 
v3.25.3
OTHER ASSETS AND LIABILITIES (Tables)
9 Months Ended
Sep. 30, 2025
Other Assets and Liabilities [Abstract]  
Schedule of Other Assets and Liabilities
Other current assets
(in thousands)September 30, 2025December 31, 2024
Prepaid expenses$39,970 $38,155 
Income tax receivables56,332 58,359 
Contract assets22,465 13,498 
Indirect tax receivable1,954 2,488 
Capped call transactions— 223 
Restricted cash— 98 
Other3,070 2,357 
$123,791 $115,178 
Other long-term assets
(in thousands)September 30, 2025December 31, 2024
Deferred commissions$99,423 $105,405 
Right of use assets59,397 62,429 
Property and equipment43,036 41,806 
Venture investments20,214 21,234 
Contract assets28,588 18,321 
Income taxes receivable14,270 13,299 
Intangible assets1,829 3,832 
Deferred income taxes3,973 4,268 
Restricted cash5,103 4,328 
Other17,884 17,127 
$293,717 $292,049 
Accrued expenses
(in thousands)September 30, 2025December 31, 2024
Cloud hosting$16,445 $1,802 
Outside professional services18,187 10,639 
Marketing and sales program1,472 2,150 
Income and other taxes4,653 5,055 
Employee related5,692 4,833 
Repurchases of common stock unsettled— 1,500 
Other5,408 5,565 
$51,857 $31,544 
Other current liabilities
(in thousands)September 30, 2025December 31, 2024
Operating lease liabilities$14,424 $14,551 
Dividends payable5,116 2,583 
Other1,591 1,732 
$21,131 $18,866 
Other long-term liabilities
(in thousands)September 30, 2025December 31, 2024
Deferred revenue$2,457 $2,121 
Income taxes payable20,983 15,956 
Other12,662 11,011 
$36,102 $29,088 
v3.25.3
SEGMENT INFORMATION (Tables)
9 Months Ended
Sep. 30, 2025
Segment Reporting [Abstract]  
Schedule of Information of Operation Income (Expense)
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in thousands)2025202420252024
Total revenue$381,350 $325,050 $1,241,495 $1,006,350 
Total cost of revenue105,893 96,706 317,917 288,310 
Selling
119,764 109,952 354,932 331,915 
Marketing
20,365 17,717 70,397 63,210 
Research and development78,756 74,157 231,826 221,695 
General and administrative42,108 35,694 107,724 84,641 
Other segment items, net (1)
(9,632)2,449 (16,954)28,111 
(Benefit from) provision for income taxes(19,268)2,765 16,790 8,369 
Net income (loss)$43,364 $(14,390)$158,863 $(19,901)
(1) Includes Litigation settlement, net of recoveries, Restructuring, Foreign currency transaction gain (loss), Interest income, Interest expense, (Loss) on capped call transactions, and Other (loss) income, net.
Schedule of Long-Lived Assets by Geographic Area
Long-lived assets related to the Company’s U.S. and international operations consist of property and equipment, which are included in Other long-term assets in the Company’s consolidated balance sheet:
(in thousands)
September 30, 2025December 31, 2024
U.S.$37,433 87 %$37,405 89 %
International5,603 13 %4,401 11 %
$43,036 100 %$41,806 100 %
v3.25.3
LEASES (Tables)
9 Months Ended
Sep. 30, 2025
Leases [Abstract]  
Schedule of Expense
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in thousands)2025202420252024
Fixed lease costs$4,128 $6,848 $11,828 $16,381 
Short-term lease costs420 381 1,330 1,334 
Variable lease costs1,351 1,863 4,909 5,235 
$5,899 $9,092 $18,067 $22,950 
Schedule of Right of Use Assets and Lease Liabilities
(in thousands)September 30, 2025December 31, 2024
Right of use assets (1)
$59,397 $62,429 
Operating lease liabilities (2)
$14,424 $14,551 
Long-term operating lease liabilities$62,402 $67,647 
(1) Included in other long-term assets.
(2) Included in other current liabilities.
Schedule of Weighted Average and Discount Rate
Weighted-average remaining lease term and discount rate for the Company’s leases were:
September 30, 2025December 31, 2024
Weighted-average remaining lease term5.7 years6.2 years
Weighted-average discount rate (1)
4.9 %4.8 %
(1) The rates implicit in the Company’s leases are not readily determinable. Therefore, the Company uses its incremental borrowing rate as the discount rate when measuring operating lease liabilities. The incremental borrowing rate represents an estimate of the interest rate the Company would incur to borrow an amount equal to the lease payments on a collateralized basis over the lease term in a similar economic environment.
Schedule of Maturities of Lease Liabilities
Maturities of lease liabilities:
(in thousands)September 30, 2025
Remainder of 2025$4,615 
202616,971 
202715,494 
202814,357 
202911,343 
20309,754 
Thereafter15,411 
Total lease payments87,945 
Less: imputed interest (1)
(11,119)
$76,826 
(1) Lease liabilities are measured at the present value of the remaining lease payments using a discount rate determined at lease commencement unless the discount rate is updated due to a lease reassessment event.
Schedule of Cash Flow Information
Nine Months Ended
September 30,
(in thousands)20252024
Cash paid for operating leases, net of tenant improvement allowances$14,502 $13,249 
Right of use assets recognized for new leases and amendments (non-cash)$4,765 $12,290 
v3.25.3
DEBT (Tables)
9 Months Ended
Sep. 30, 2025
Debt Disclosure [Abstract]  
Schedule of Carrying Value and Interest Expense Related to the Notes
Carrying value of the Notes:
(in thousands)September 30, 2025December 31, 2024
Principal$— $467,864 
Unamortized issuance costs— (394)
Convertible senior notes, net$— $467,470 

Interest expense related to the Notes:
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in thousands)2025202420252024
Contractual interest expense (0.75% coupon)
$— $941 $595 $2,825 
Amortization of issuance costs
— 621 394 1,857 
$— $1,562 $989 $4,682 
Schedule of Change in Capped Call Transactions
Change in capped call transactions:
Nine Months Ended
September 30,
(in thousands)20252024
January 1,$223 $893 
Fair value adjustment(223)(667)
September 30,$— $226 
v3.25.3
RESTRUCTURING (Tables)
9 Months Ended
Sep. 30, 2025
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring Activities and Accrued Employee Severance and Related Benefits
The Company has undertaken the following restructuring activities as it optimizes its go-to-market strategy and reassesses its office space needs:
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in thousands)2025202420252024
Employee severance and related costs
$(11)$(397)$(68)$(634)
Office space reductions (1)
2,882 30 3,917 
      Restructuring
$(5)$2,485 $(38)$3,283 
(1) These primarily relate to non-cash operating lease adjustments.
Restructuring activity:
Accrued employee severance and related costs:
Nine Months Ended
September 30,
(in thousands)20252024
January 1,$2,000 $8,095 
Costs incurred(68)(634)
Cash disbursements(1,681)(4,214)
Currency translation adjustments115 (93)
September 30, (1)
$366 $3,154 
(1) Included in accrued compensation and related expenses.
v3.25.3
FAIR VALUE MEASUREMENTS (Tables)
9 Months Ended
Sep. 30, 2025
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value
Assets and liabilities measured at fair value on a recurring basis:
September 30, 2025December 31, 2024
(in thousands)Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Cash equivalents$8,157 $5,119 $— $13,276 $5,318 $148,926 $— $154,244 
Marketable securities $— $202,663 $— $202,663 $— $402,870 $— $402,870 
Capped Call Transactions
$— $— $— $— $— $223 $— $223 
Venture investments$— $— $20,214 $20,214 $— $— $21,234 $21,234 
Schedule of Changes in Venture Investments
Changes in venture investments:
Nine Months Ended
September 30,
(in thousands)20252024
January 1,$21,234 $19,450 
New investments13,129 350 
Sales of investments(33,223)— 
Changes in foreign exchange rates129 106 
Changes in fair value:
included in other (loss) income, net
19,480 1,628 
included in other comprehensive income (loss)
(535)(362)
September 30,$20,214 $21,172 
v3.25.3
REVENUE (Tables)
9 Months Ended
Sep. 30, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of Geographic Revenue
Revenues by geography are determined based on client location:
Three Months Ended
September 30,
Nine Months Ended
September 30,
(Dollars in thousands)
2025202420252024
U.S.$185,132 49 %$156,135 48 %$662,440 54 %$526,332 53 %
Other Americas23,511 %28,836 %76,884 %71,936 %
United Kingdom (“U.K.”)53,099 14 %37,593 12 %134,475 11 %108,338 11 %
Europe (excluding U.K.), Middle East, and Africa 64,410 17 %60,048 18 %202,886 16 %175,255 17 %
Asia-Pacific55,198 14 %42,438 13 %164,810 13 %124,489 12 %
$381,350 100 %$325,050 100 %$1,241,495 100 %$1,006,350 100 %
Schedule of Revenue Streams
Revenue streams
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in thousands)
2025202420252024
Pega Cloud$184,549 $144,108 $502,415 $409,096 
Maintenance79,649 80,702 235,288 242,047 
Consulting56,394 54,364 174,639 160,451 
Revenue recognized over time320,592 279,174 912,342 811,594 
Subscription license60,600 45,420 327,118 193,405 
Perpetual license158 456 2,035 1,351 
Revenue recognized at a point in time60,758 45,876 329,153 194,756 
Total revenue$381,350 $325,050 $1,241,495 $1,006,350 
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in thousands)2025202420252024
Pega Cloud$184,549 $144,108 $502,415 $409,096 
Maintenance79,649 80,702 235,288 242,047 
Subscription services264,198 224,810 737,703 651,143 
Subscription license60,600 45,420 327,118 193,405 
Subscription324,798 270,230 1,064,821 844,548 
Consulting56,394 54,364 174,639 160,451 
Perpetual license158 456 2,035 1,351 
Total revenue$381,350 $325,050 $1,241,495 $1,006,350 
Schedule of Remaining Performance Obligations
Expected future revenue from existing non-cancellable contracts:
As of September 30, 2025:
(Dollars in thousands)Subscription servicesSubscription licensePerpetual licenseConsultingTotal
Pega CloudMaintenance
1 year or less
$609,511 $199,651 $46,228 $158 $43,979 $899,527 51 %
1-2 years
319,940 71,730 4,404 — 2,478 398,552 23 %
2-3 years
164,125 48,668 746 — 114 213,653 12 %
Greater than 3 years
195,133 40,385 7,220 — 56 242,794 14 %
$1,288,709 $360,434 $58,598 $158 $46,627 $1,754,526 100 %
As of September 30, 2024:
(Dollars in thousands)Subscription servicesSubscription licensePerpetual licenseConsultingTotal
Pega CloudMaintenance
1 year or less
$495,637 $188,905 $38,175 $2,252 $54,203 $779,172 53 %
1-2 years
310,020 63,701 9,686 317 3,062 386,786 26 %
2-3 years
146,877 26,436 3,046 — 2,008 178,367 12 %
Greater than 3 years
112,002 18,854 102 — — 130,958 %
$1,064,536 $297,896 $51,009 $2,569 $59,273 $1,475,283 100 %
v3.25.3
STOCKHOLDERS' EQUITY (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expense
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in thousands)2025202420252024
Cost of revenue
$6,626 $6,894 $21,737 $20,558 
Selling and marketing
15,009 14,169 45,168 41,621 
Research and development
7,914 7,308 23,789 22,779 
General and administrative
13,492 8,842 30,502 23,260 
$43,041 $37,213 $121,196 $108,218 
Income tax benefit
$(547)$(512)$(1,700)$(1,377)
Schedule of Stock-based Compensation Expense Grants
Nine Months Ended
September 30, 2025
(in thousands)
Quantity
Total Fair Value
Restricted stock units (1)
2,055$82,098 
Non-qualified stock options
3,296 $53,132 
Performance stock options (2)
1,362 $35,324 
Common stock
18$928 
(1) Includes units issued when employees elect to receive 50% of the employee’s target incentive compensation under the Company’s Corporate Incentive Compensation Plan (the “CICP”) in the form of RSUs instead of cash.
(2) Performance stock options allow the holder to purchase a specified number of Common Stock shares at an exercise price equal to or greater than the shares' fair market value at the grant date. The performance stock options granted in the nine months ended September 30, 2025 vest quarterly over two years, beginning after the achievement of specific performance conditions. The options expire ten years from the grant date.
v3.25.3
INCOME TAXES (Tables)
9 Months Ended
Sep. 30, 2025
Income Tax Disclosure [Abstract]  
Schedule of Effective Income Tax Rate
Effective income tax rate
Nine Months Ended
September 30,
(Dollars in thousands)20252024
(Benefit from) provision for income taxes$16,790 $8,369 
Effective income tax rate10 %(73)%
v3.25.3
EARNINGS (LOSS) PER SHARE (Tables)
9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
Schedule of Calculation of Earnings (Loss) Per Share
Calculation of earnings (loss) per share:
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in thousands, except per share amounts) (1)
2025202420252024
Net income (loss)$43,364 $(14,390)$158,863 $(19,901)
Weighted-average common shares outstanding170,567 171,250 171,045 170,036 
Earnings (loss) per share, basic$0.25 $(0.08)$0.93 $(0.12)
Net income (loss)$43,364 $(14,390)$158,863 $(19,901)
Notes - interest expense, net of tax
— — 742 — 
Numerator for diluted EPS $43,364 $(14,390)$159,605 $(19,901)
Weighted-average effect of dilutive securities:
Notes
1,599
Stock options10,1138,971
RSUs3,4153,390
Effect of dilutive securities13,52813,960
Weighted-average common shares outstanding, assuming dilution (2) (3) (4)
184,095171,250185,005170,036
Earnings (loss) per share, diluted$0.24 $(0.08)$0.86 $(0.12)
Outstanding anti-dilutive stock options and RSUs (5)
549,0562677,364
(1) The number of shares and per share amounts have been recast for all prior periods presented to reflect the effect of the Company’s Stock Split effected in the form of a stock dividend distributed on June 20, 2025.
(2) All securities are excluded when their inclusion would be anti-dilutive.
(3) The weighted-average shares underlying the conversion options in the Company’s Notes are included using the if-converted method, if dilutive in the period.
(4) The Company’s Capped Call Transactions represented the equivalent number of shares of the Company’s common stock (representing the number of shares for which the Notes are convertible). The Capped Call Transactions are excluded from weighted-average common shares outstanding, assuming dilution, in all periods as their effect would be anti-dilutive.
(5) Outstanding stock options and RSUs that were anti-dilutive under the treasury stock method in the period were excluded from the computation of diluted earnings (loss) per share. These awards may be dilutive in the future.
v3.25.3
BASIS OF PRESENTATION (Details)
Feb. 12, 2025
$ / shares
shares
Sep. 30, 2025
shares
Jun. 20, 2025
$ / shares
Feb. 11, 2025
shares
Dec. 31, 2024
shares
Accounting Policies [Abstract]          
Stock split, conversion ratio 2        
Common stock, par value (in dollars per share) | $ / shares $ 0.01   $ 0.01    
Common stock, shares authorized (in shares) | shares 400,000,000 400,000,000   200,000,000 400,000,000
v3.25.3
MARKETABLE SECURITIES - Schedule of Marketable Securities (Details) - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Marketable Securities [Line Items]    
Amortized Cost $ 202,192 $ 402,948
Unrealized Gains 572 64
Unrealized Losses (101) (142)
Fair Value 202,663 402,870
Government debt    
Marketable Securities [Line Items]    
Amortized Cost 10,500 11,851
Unrealized Gains 11 1
Unrealized Losses (8) (19)
Fair Value 10,503 11,833
Corporate debt    
Marketable Securities [Line Items]    
Amortized Cost 191,692 391,097
Unrealized Gains 561 63
Unrealized Losses (93) (123)
Fair Value $ 192,160 $ 391,037
v3.25.3
MARKETABLE SECURITIES - Narrative (Details)
Sep. 30, 2025
Investments, Debt and Equity Securities [Abstract]  
Marketable securities weighted-average remaining maturity 1 year 4 months 24 days
v3.25.3
RECEIVABLES, CONTRACT ASSETS, AND DEFERRED REVENUE - Schedule of Receivables (Details) - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Receivables [Abstract]    
Accounts receivable, net $ 160,919 $ 305,468
Unbilled receivables, net 175,732 173,085
Long-term unbilled receivables, net 105,863 61,407
Total receivables $ 442,514 $ 539,960
v3.25.3
RECEIVABLES, CONTRACT ASSETS, AND DEFERRED REVENUE - Schedule of Unbilled Receivables (Details)
$ in Thousands
Sep. 30, 2025
USD ($)
Receivables [Abstract]  
1 year or less $ 175,732
1-2 years 63,974
2-5 years 41,889
Total $ 281,595
Percentage of unbilled receivables, 1 year or less 62.00%
Percentage of unbilled receivables, 1-2 years 23.00%
Percentage of unbilled receivables, 2-5 years 15.00%
Total percentage of unbilled receivables 100.00%
v3.25.3
RECEIVABLES, CONTRACT ASSETS, AND DEFERRED REVENUE- Schedule of Unbilled Receivables by Contract Effective Date (Details)
$ in Thousands
Sep. 30, 2025
USD ($)
Receivables [Abstract]  
2025 $ 135,540
2024 86,021
2023 52,162
2022 3,714
2021 and prior 4,158
Unbilled revenue total $ 281,595
2025 48.00%
2024 31.00%
2023 19.00%
2022 1.00%
2021 and prior 1.00%
Total percentage of unbilled revenue 100.00%
v3.25.3
RECEIVABLES, CONTRACT ASSETS, AND DEFERRED REVENUE - Schedule of Total Accounts Receivable and Unbilled Receivables (Details)
9 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Concentration Risk [Line Items]      
Total receivables 100.00% 100.00%  
Client A | Credit Concentration Risk | Accounts receivable      
Concentration Risk [Line Items]      
Total receivables     20.00%
Client A | Credit Concentration Risk | Unbilled receivables      
Concentration Risk [Line Items]      
Total receivables     0.00%
Client A | Credit Concentration Risk | Total receivables      
Concentration Risk [Line Items]      
Total receivables     11.00%
Client B | Credit Concentration Risk | Accounts receivable      
Concentration Risk [Line Items]      
Total receivables 0.00%    
Client B | Credit Concentration Risk | Unbilled receivables      
Concentration Risk [Line Items]      
Total receivables 18.00%    
Client B | Credit Concentration Risk | Total receivables      
Concentration Risk [Line Items]      
Total receivables 12.00%    
v3.25.3
RECEIVABLES, CONTRACT ASSETS, AND DEFERRED REVENUE - Schedule of Contract Assets and Deferred Revenue (Details) - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Receivables [Abstract]    
Contract assets $ 22,465 $ 13,498
Long-term contract assets 28,588 18,321
Total contract assets 51,053 31,819
Deferred revenue 404,757 423,910
Long-term deferred revenue 2,457 2,121
Total deferred revenue $ 407,214 $ 426,031
v3.25.3
RECEIVABLES, CONTRACT ASSETS, AND DEFERRED REVENUE - Narrative (Details)
$ in Millions
9 Months Ended
Sep. 30, 2025
USD ($)
Receivables [Abstract]  
Revenue recognized during the period that was included in deferred revenue $ 384
v3.25.3
DEFERRED COMMISSIONS - Schedule of Impairment of Deferred Commissions (Details) - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
Deferred commissions $ 99,423 $ 105,405
v3.25.3
DEFERRED COMMISSIONS - Schedule of Amortization of Deferred Commissions (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]        
Amortization of deferred commissions $ 16,916 $ 14,867 $ 50,494 $ 47,143
v3.25.3
GOODWILL AND OTHER INTANGIBLES - Schedule of Goodwill (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Goodwill [Roll Forward]    
Beginning balance $ 81,113 $ 81,611
Currency translation adjustments 289 (43)
Ending balance $ 81,402 $ 81,568
v3.25.3
GOODWILL AND OTHER INTANGIBLES - Schedule of Intangibles (Details) - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Goodwill and Other Intangible Assets [Line Items]    
Cost $ 136,637 $ 136,583
Accumulated Amortization (134,808) (132,751)
Net Book Value 1,829 3,832
Client-related    
Goodwill and Other Intangible Assets [Line Items]    
Cost 63,161 63,107
Accumulated Amortization (62,476) (61,395)
Net Book Value 685 1,712
Technology    
Goodwill and Other Intangible Assets [Line Items]    
Cost 68,115 68,115
Accumulated Amortization (66,971) (65,995)
Net Book Value 1,144 2,120
Other    
Goodwill and Other Intangible Assets [Line Items]    
Cost 5,361 5,361
Accumulated Amortization (5,361) (5,361)
Net Book Value $ 0 $ 0
Minimum | Client-related    
Goodwill and Other Intangible Assets [Line Items]    
Useful Lives 4 years 4 years
Minimum | Technology    
Goodwill and Other Intangible Assets [Line Items]    
Useful Lives 2 years 2 years
Minimum | Other    
Goodwill and Other Intangible Assets [Line Items]    
Useful Lives 1 year 1 year
Maximum | Client-related    
Goodwill and Other Intangible Assets [Line Items]    
Useful Lives 10 years 10 years
Maximum | Technology    
Goodwill and Other Intangible Assets [Line Items]    
Useful Lives 10 years 10 years
Maximum | Other    
Goodwill and Other Intangible Assets [Line Items]    
Useful Lives 5 years 5 years
v3.25.3
GOODWILL AND OTHER INTANGIBLES - Schedule of Future Estimated Amortization of Intangibles Assets (Details) - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]    
Remainder of 2025 $ 627  
2026 874  
2027 328  
Net Book Value $ 1,829 $ 3,832
v3.25.3
GOODWILL AND OTHER INTANGIBLES - Schedule of Amortization of Intangible Assets (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Intangible Asset, Acquired, Finite-Lived [Line Items]        
Amortization of intangible assets $ 627 $ 700 $ 2,003 $ 2,453
Cost of revenue        
Intangible Asset, Acquired, Finite-Lived [Line Items]        
Amortization of intangible assets 284 357 975 1,425
Selling and marketing        
Intangible Asset, Acquired, Finite-Lived [Line Items]        
Amortization of intangible assets $ 343 $ 343 $ 1,028 $ 1,028
v3.25.3
OTHER ASSETS AND LIABILITIES (Details) - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Sep. 30, 2024
Other current assets      
Prepaid expenses $ 39,970 $ 38,155  
Income tax receivables 56,332 58,359  
Contract assets 22,465 13,498  
Indirect tax receivable 1,954 2,488  
Capped call transactions 0 223  
Restricted cash 0 98 $ 184
Other 3,070 2,357  
Other current assets 123,791 115,178  
Other long-term assets      
Deferred commissions 99,423 105,405  
Right of use assets 59,397 62,429  
Property and equipment 43,036 41,806  
Venture investments 20,214 21,234  
Contract assets 28,588 18,321  
Income taxes receivable 14,270 13,299  
Intangible assets 1,829 3,832  
Deferred income taxes 3,973 4,268  
Restricted cash 5,103 4,328 $ 11,232
Other 17,884 17,127  
Other long-term assets 293,717 292,049  
Accrued expenses      
Cloud hosting 16,445 1,802  
Outside professional services 18,187 10,639  
Marketing and sales program 1,472 2,150  
Income and other taxes 4,653 5,055  
Employee related 5,692 4,833  
Repurchases of common stock unsettled 0 1,500  
Other 5,408 5,565  
Accrued expenses 51,857 31,544  
Other current liabilities      
Operating lease liabilities 14,424 14,551  
Dividends payable 5,116 2,583  
Other 1,591 1,732  
Other current liabilities 21,131 18,866  
Other long-term liabilities      
Deferred revenue 2,457 2,121  
Income taxes payable 20,983 15,956  
Other 12,662 11,011  
Other long-term liabilities $ 36,102 $ 29,088  
v3.25.3
SEGMENT INFORMATION - Narrative (Details)
9 Months Ended
Sep. 30, 2025
segment
Segment Reporting [Abstract]  
Number of operating segments 1
Number of reportable segments 1
v3.25.3
SEGMENT INFORMATION - Schedule of Information of Operation Income (Expense) (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Segment Reporting Information [Line Items]                
Total revenue $ 381,350     $ 325,050     $ 1,241,495 $ 1,006,350
Total cost of revenue 105,893     96,706     317,917 288,310
Research and development 78,756     74,157     231,826 221,695
General and administrative 42,108     35,694     107,724 84,641
(Benefit from) provision for income taxes (19,268)     2,765     16,790 8,369
Net income (loss) 43,364 $ 30,077 $ 85,422 (14,390) $ 6,613 $ (12,124) 158,863 (19,901)
Reportable Segment                
Segment Reporting Information [Line Items]                
Total revenue 381,350     325,050     1,241,495 1,006,350
Total cost of revenue 105,893     96,706     317,917 288,310
Selling 119,764     109,952     354,932 331,915
Marketing 20,365     17,717     70,397 63,210
Research and development 78,756     74,157     231,826 221,695
General and administrative 42,108     35,694     107,724 84,641
Other segment items, net (9,632)     2,449     (16,954) 28,111
(Benefit from) provision for income taxes (19,268)     2,765     16,790 8,369
Net income (loss) $ 43,364     $ (14,390)     $ 158,863 $ (19,901)
v3.25.3
SEGMENT INFORMATION - Schedule of Long-Lived Assets by Geographic Area (Details) - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Geographic Areas, Long-Lived Assets [Abstract]    
Long-lived assets $ 43,036 $ 41,806
Long-lived assets percentage 100.00% 100.00%
U.S.    
Geographic Areas, Long-Lived Assets [Abstract]    
Long-lived assets $ 37,433 $ 37,405
Long-lived assets percentage 87.00% 89.00%
International    
Geographic Areas, Long-Lived Assets [Abstract]    
Long-lived assets $ 5,603 $ 4,401
Long-lived assets percentage 13.00% 11.00%
v3.25.3
LEASES - Schedule of Expense (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Leases [Abstract]        
Fixed lease costs $ 4,128 $ 6,848 $ 11,828 $ 16,381
Short-term lease costs 420 381 1,330 1,334
Variable lease costs 1,351 1,863 4,909 5,235
Lease, cost $ 5,899 $ 9,092 $ 18,067 $ 22,950
v3.25.3
LEASES - Schedule of Right of Use Assets and Lease Liabilities (Details) - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Leases [Abstract]    
Right of use assets $ 59,397 $ 62,429
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Other long-term assets Other long-term assets
Operating lease liabilities $ 14,424 $ 14,551
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Other current liabilities Other current liabilities
Long-term operating lease liabilities $ 62,402 $ 67,647
v3.25.3
LEASES - Schedule of Weighted Average and Discount Rate (Details)
Sep. 30, 2025
Dec. 31, 2024
Leases [Abstract]    
Weighted-average remaining lease term 5 years 8 months 12 days 6 years 2 months 12 days
Weighted-average discount rate 4.90% 4.80%
v3.25.3
LEASES - Schedule of Maturities of Lease Liabilities (Details)
$ in Thousands
Sep. 30, 2025
USD ($)
Leases [Abstract]  
Remainder of 2025 $ 4,615
2026 16,971
2027 15,494
2028 14,357
2029 11,343
2030 9,754
Thereafter 15,411
Total lease payments 87,945
Less: imputed interest (11,119)
Total lease liability $ 76,826
v3.25.3
LEASES - Schedule of Cash Flow Information (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Leases [Abstract]    
Cash paid for operating leases, net of tenant improvement allowances $ 14,502 $ 13,249
Right of use assets recognized for new leases and amendments (non-cash) $ 4,765 $ 12,290
v3.25.3
DEBT - Convertible Senior Notes and Capped Calls (Details) - Notes
1 Months Ended 3 Months Ended 9 Months Ended
Feb. 29, 2020
USD ($)
$ / shares
Sep. 30, 2025
Mar. 31, 2025
USD ($)
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Debt Instrument [Line Items]            
Face amount $ 600,000,000          
Interest rate 0.75% 0.75%   0.75% 0.75% 0.75%
Principal amount repurchased     $ 469,600,000      
Initial conversion rate 0.014809          
Initial conversion price (in dollars per share) | $ / shares $ 67.53          
Average interest rate     1.20%     1.20%
v3.25.3
DEBT - Schedule of Carrying Value of the Notes (Details) - Notes - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Debt Instrument [Line Items]    
Principal $ 0 $ 467,864
Unamortized issuance costs 0 (394)
Convertible senior notes, net $ 0 $ 467,470
v3.25.3
DEBT - Schedule of Interest Expense Related to the Notes (Details) - Notes - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Feb. 29, 2020
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Debt Instrument [Line Items]          
Interest rate 0.75% 0.75% 0.75% 0.75% 0.75%
Contractual interest expense (0.75% coupon)   $ 0 $ 941 $ 595 $ 2,825
Amortization of issuance costs   0 621 394 1,857
Interest expense   $ 0 $ 1,562 $ 989 $ 4,682
v3.25.3
DEBT - Capped Call Transactions (Details) - shares
shares in Millions
1 Months Ended
Feb. 29, 2020
Dec. 31, 2024
Debt Instrument [Line Items]    
Number of shares issuable upon conversion (in shares) 8.8  
Capped Call Transactions    
Debt Instrument [Line Items]    
Number of shares issuable upon conversion (in shares)   7.0
v3.25.3
DEBT - Schedule of Change in Capped Call Transactions (Details) - Capped Call Transactions - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Beginning balance $ 223 $ 893
Fair value adjustment (223) (667)
Ending balance $ 0 $ 226
v3.25.3
DEBT - Credit Facility (Details)
1 Months Ended
Nov. 30, 2019
USD ($)
Sep. 30, 2025
USD ($)
Dec. 31, 2024
USD ($)
PNC Bank, National Association      
Debt Instrument [Line Items]      
Minimum consolidated coverage ratio   3.5  
PNC Bank, National Association | Credit Agreement      
Debt Instrument [Line Items]      
Maximum consolidated net leverage ratio   3.5  
Revolving Credit Facility | Line of Credit      
Debt Instrument [Line Items]      
Outstanding letters of credit   $ 26,700,000 $ 27,300,000
Remaining borrowing capacity   $ 0 $ 0
Revolving Credit Facility | PNC Bank, National Association | Line of Credit      
Debt Instrument [Line Items]      
Revolving credit agreement term 5 years    
Senior notes $ 100,000,000    
Increase in aggregate commitment amount $ 200,000,000    
v3.25.3
RESTRUCTURING - Schedule of Restructuring Activities (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Restructuring Cost and Reserve [Line Items]        
Restructuring $ (5) $ 2,485 $ (38) $ 3,283
Employee severance and related costs        
Restructuring Cost and Reserve [Line Items]        
Restructuring (11) (397) (68) (634)
Office space reductions        
Restructuring Cost and Reserve [Line Items]        
Restructuring $ 6 $ 2,882 $ 30 $ 3,917
v3.25.3
RESTRUCTURING - Schedule of Accrued Employee Severance and Related Costs (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Restructuring Reserve [Roll Forward]        
Costs incurred $ (5) $ 2,485 $ (38) $ 3,283
Accrued employee severance and related costs        
Restructuring Reserve [Roll Forward]        
Beginning balance     2,000 8,095
Costs incurred (11) (397) (68) (634)
Cash disbursements     (1,681) (4,214)
Currency translation adjustments     115 (93)
Ending balance $ 366 $ 3,154 $ 366 $ 3,154
v3.25.3
FAIR VALUE MEASUREMENTS - Schedule of Assets and Liabilities Measured at Fair Value (Details) - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Fair Value Assets    
Marketable securities $ 202,663 $ 402,870
Capped Call Transactions 0 223
Cash equivalents    
Fair Value Assets    
Cash equivalents 13,276 154,244
Venture investments    
Fair Value Assets    
Venture investments 20,214 21,234
Level 1    
Fair Value Assets    
Marketable securities 0 0
Capped Call Transactions 0 0
Level 1 | Cash equivalents    
Fair Value Assets    
Cash equivalents 8,157 5,318
Level 1 | Venture investments    
Fair Value Assets    
Venture investments 0 0
Level 2    
Fair Value Assets    
Marketable securities 202,663 402,870
Capped Call Transactions 0 223
Level 2 | Cash equivalents    
Fair Value Assets    
Cash equivalents 5,119 148,926
Level 2 | Venture investments    
Fair Value Assets    
Venture investments 0 0
Level 3    
Fair Value Assets    
Marketable securities 0 0
Capped Call Transactions 0 0
Level 3 | Cash equivalents    
Fair Value Assets    
Cash equivalents 0 0
Level 3 | Venture investments    
Fair Value Assets    
Venture investments $ 20,214 $ 21,234
v3.25.3
FAIR VALUE MEASUREMENTS - Schedule of Changes in Venture Investments (Details) - Privately Held Investment - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Beginning balance $ 21,234 $ 19,450
New investments 13,129 350
Sales of investments (33,223) 0
Changes in foreign exchange rates 129 106
Changes in fair value:    
included in other (loss) income, net 19,480 1,628
included in other comprehensive income (loss) (535) (362)
Ending balance $ 20,214 $ 21,172
v3.25.3
FAIR VALUE MEASUREMENTS - Narrative (Details)
$ in Millions
3 Months Ended
Jun. 30, 2025
USD ($)
investee
Dec. 31, 2024
USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Convertible debt fair value   $ 463.9
Privately Held Investment    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Number of investees sold | investee 1  
Gross consideration received upon sale of investee $ 33.2  
Cash proceeds from sale of investee 22.1  
Equity consideration from sale of investee 11.1  
Gain on sale of investee $ 18.7  
v3.25.3
REVENUE - Schedule of Geographic Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Disaggregation of Revenue [Line Items]        
Total revenue $ 381,350 $ 325,050 $ 1,241,495 $ 1,006,350
Percent of total revenue     100.00% 100.00%
U.S.        
Disaggregation of Revenue [Line Items]        
Total revenue 185,132 156,135 $ 662,440 $ 526,332
Other Americas        
Disaggregation of Revenue [Line Items]        
Total revenue 23,511 28,836 76,884 71,936
United Kingdom (“U.K.”)        
Disaggregation of Revenue [Line Items]        
Total revenue 53,099 37,593 134,475 108,338
Europe (excluding U.K.), Middle East, and Africa        
Disaggregation of Revenue [Line Items]        
Total revenue 64,410 60,048 202,886 175,255
Asia-Pacific        
Disaggregation of Revenue [Line Items]        
Total revenue $ 55,198 $ 42,438 $ 164,810 $ 124,489
Revenue Benchmark | Geographic Concentration Risk        
Disaggregation of Revenue [Line Items]        
Percent of total revenue 100.00% 100.00%    
Revenue Benchmark | U.S. | Geographic Concentration Risk        
Disaggregation of Revenue [Line Items]        
Percent of total revenue 49.00% 48.00% 54.00% 53.00%
Revenue Benchmark | Other Americas | Geographic Concentration Risk        
Disaggregation of Revenue [Line Items]        
Percent of total revenue 6.00% 9.00% 6.00% 7.00%
Revenue Benchmark | United Kingdom (“U.K.”) | Geographic Concentration Risk        
Disaggregation of Revenue [Line Items]        
Percent of total revenue 14.00% 12.00% 11.00% 11.00%
Revenue Benchmark | Europe (excluding U.K.), Middle East, and Africa | Geographic Concentration Risk        
Disaggregation of Revenue [Line Items]        
Percent of total revenue 17.00% 18.00% 16.00% 17.00%
Revenue Benchmark | Asia-Pacific | Geographic Concentration Risk        
Disaggregation of Revenue [Line Items]        
Percent of total revenue 14.00% 13.00% 13.00% 12.00%
v3.25.3
REVENUE - Schedule of Revenue Streams (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Disaggregation of Revenue [Line Items]        
Total revenue $ 381,350 $ 325,050 $ 1,241,495 $ 1,006,350
Pega Cloud        
Disaggregation of Revenue [Line Items]        
Total revenue 184,549 144,108 502,415 409,096
Maintenance        
Disaggregation of Revenue [Line Items]        
Total revenue 79,649 80,702 235,288 242,047
Consulting        
Disaggregation of Revenue [Line Items]        
Total revenue 56,394 54,364 174,639 160,451
Subscription services        
Disaggregation of Revenue [Line Items]        
Total revenue 264,198 224,810 737,703 651,143
Subscription license        
Disaggregation of Revenue [Line Items]        
Total revenue 60,600 45,420 327,118 193,405
Subscription        
Disaggregation of Revenue [Line Items]        
Total revenue 324,798 270,230 1,064,821 844,548
Perpetual license        
Disaggregation of Revenue [Line Items]        
Total revenue 158 456 2,035 1,351
Revenue recognized over time        
Disaggregation of Revenue [Line Items]        
Total revenue 320,592 279,174 912,342 811,594
Revenue recognized over time | Pega Cloud        
Disaggregation of Revenue [Line Items]        
Total revenue 184,549 144,108 502,415 409,096
Revenue recognized over time | Maintenance        
Disaggregation of Revenue [Line Items]        
Total revenue 79,649 80,702 235,288 242,047
Revenue recognized over time | Consulting        
Disaggregation of Revenue [Line Items]        
Total revenue 56,394 54,364 174,639 160,451
Revenue recognized at a point in time        
Disaggregation of Revenue [Line Items]        
Total revenue 60,758 45,876 329,153 194,756
Revenue recognized at a point in time | Subscription license        
Disaggregation of Revenue [Line Items]        
Total revenue 60,600 45,420 327,118 193,405
Revenue recognized at a point in time | Perpetual license        
Disaggregation of Revenue [Line Items]        
Total revenue $ 158 $ 456 $ 2,035 $ 1,351
v3.25.3
REVENUE - Schedule of Remaining Performance Obligations (Details) - USD ($)
$ in Thousands
Sep. 30, 2025
Sep. 30, 2024
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation $ 1,754,526 $ 1,475,283
Revenue remaining performance obligation, percentage 100.00% 100.00%
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-10-01    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation   $ 779,172
Revenue remaining performance obligation, percentage   53.00%
Expected timing of satisfaction   1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-10-01    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation $ 899,527 $ 386,786
Revenue remaining performance obligation, percentage 51.00% 26.00%
Expected timing of satisfaction 1 year 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-10-01    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation $ 398,552 $ 178,367
Revenue remaining performance obligation, percentage 23.00% 12.00%
Expected timing of satisfaction 1 year 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-10-01    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation $ 213,653 $ 130,958
Revenue remaining performance obligation, percentage 12.00% 9.00%
Expected timing of satisfaction 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-10-01    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation $ 242,794  
Revenue remaining performance obligation, percentage 14.00%  
Expected timing of satisfaction  
Pega Cloud    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation $ 1,288,709 $ 1,064,536
Pega Cloud | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-10-01    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation   $ 495,637
Expected timing of satisfaction   1 year
Pega Cloud | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-10-01    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation $ 609,511 $ 310,020
Expected timing of satisfaction 1 year 1 year
Pega Cloud | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-10-01    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation $ 319,940 $ 146,877
Expected timing of satisfaction 1 year 1 year
Pega Cloud | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-10-01    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation $ 164,125 $ 112,002
Expected timing of satisfaction 1 year
Pega Cloud | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-10-01    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation $ 195,133  
Expected timing of satisfaction  
Maintenance    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation $ 360,434 $ 297,896
Maintenance | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-10-01    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation   $ 188,905
Expected timing of satisfaction   1 year
Maintenance | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-10-01    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation $ 199,651 $ 63,701
Expected timing of satisfaction 1 year 1 year
Maintenance | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-10-01    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation $ 71,730 $ 26,436
Expected timing of satisfaction 1 year 1 year
Maintenance | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-10-01    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation $ 48,668 $ 18,854
Expected timing of satisfaction 1 year
Maintenance | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-10-01    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation $ 40,385  
Expected timing of satisfaction  
Subscription license    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation $ 58,598 $ 51,009
Subscription license | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-10-01    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation   $ 38,175
Expected timing of satisfaction   1 year
Subscription license | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-10-01    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation $ 46,228 $ 9,686
Expected timing of satisfaction 1 year 1 year
Subscription license | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-10-01    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation $ 4,404 $ 3,046
Expected timing of satisfaction 1 year 1 year
Subscription license | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-10-01    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation $ 746 $ 102
Expected timing of satisfaction 1 year
Subscription license | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-10-01    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation $ 7,220  
Expected timing of satisfaction  
Perpetual license    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation $ 158 $ 2,569
Perpetual license | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-10-01    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation   $ 2,252
Expected timing of satisfaction   1 year
Perpetual license | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-10-01    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation $ 158 $ 317
Expected timing of satisfaction 1 year 1 year
Perpetual license | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-10-01    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation $ 0 $ 0
Expected timing of satisfaction 1 year 1 year
Perpetual license | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-10-01    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation $ 0 $ 0
Expected timing of satisfaction 1 year
Perpetual license | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-10-01    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation $ 0  
Expected timing of satisfaction  
Consulting    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation $ 46,627 $ 59,273
Consulting | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-10-01    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation   $ 54,203
Expected timing of satisfaction   1 year
Consulting | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-10-01    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation $ 43,979 $ 3,062
Expected timing of satisfaction 1 year 1 year
Consulting | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-10-01    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation $ 2,478 $ 2,008
Expected timing of satisfaction 1 year 1 year
Consulting | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-10-01    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation $ 114 $ 0
Expected timing of satisfaction 1 year
Consulting | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-10-01    
Disaggregation of Revenue [Line Items]    
Revenue remaining performance obligation $ 56  
Expected timing of satisfaction  
v3.25.3
STOCKHOLDERS' EQUITY - Schedule of Stock-based Compensation Expense (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Total stock-based compensation before tax $ 43,041 $ 37,213 $ 121,196 $ 108,218
Income tax benefit (547) (512) (1,700) (1,377)
Cost of revenue        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Total stock-based compensation before tax 6,626 6,894 21,737 20,558
Selling and marketing        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Total stock-based compensation before tax 15,009 14,169 45,168 41,621
Research and development        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Total stock-based compensation before tax 7,914 7,308 23,789 22,779
General and administrative        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Total stock-based compensation before tax $ 13,492 $ 8,842 $ 30,502 $ 23,260
v3.25.3
STOCKHOLDERS' EQUITY - Narrative (Details) - USD ($)
$ / shares in Units, shares in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Sep. 30, 2025
Apr. 22, 2025
Share-Based Payment Arrangement [Abstract]            
Unrecognized stock-based compensation expense $ 129,000,000       $ 129,000,000  
Weighted-average period of recognition of unrecognized stock-based compensation expense         1 year 9 months 18 days  
Share repurchase program, increase to authorized amount           $ 500,000,000
Share repurchase program, authorized amount           $ 810,000,000
Stock repurchase program, remaining authorized repurchase amount 347,300,000       $ 347,300,000  
Repurchase of common stock (in shares)         8.7  
Repurchase of common stock $ 142,576,000 $ 132,485,000 $ 118,704,000 $ 11,749,000 $ 393,200,000  
Shares repurchased, average price per share (in dollars per share)         $ 44.97  
v3.25.3
STOCKHOLDERS' EQUITY - Schedule of Stock-based Compensation Expense Grants (Details)
shares in Thousands, $ in Thousands
9 Months Ended
Sep. 30, 2025
USD ($)
shares
Restricted stock units  
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]  
Quantity (in shares) | shares 2,055
Total Fair Value | $ $ 82,098
Restricted stock units | Corporate Incentive Compensation Plan  
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]  
Employee’s target incentive compensation percentage 50.00%
Non-qualified stock options  
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]  
Non-qualified stock options (in shares) | shares 3,296
Total Fair Value | $ $ 53,132
Performance stock options  
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]  
Quantity (in shares) | shares 1,362
Total Fair Value | $ $ 35,324
Vesting period 2 years
Expiration term 10 years
Common stock  
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]  
Quantity (in shares) | shares 18
Total Fair Value | $ $ 928
v3.25.3
INCOME TAXES (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Tax Disclosure [Abstract]        
(Benefit from) provision for income taxes $ (19,268) $ 2,765 $ 16,790 $ 8,369
Effective income tax rate     10.00% (73.00%)
v3.25.3
EARNINGS (LOSS) PER SHARE (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Basic                
Net income (loss) $ 43,364 $ 30,077 $ 85,422 $ (14,390) $ 6,613 $ (12,124) $ 158,863 $ (19,901)
Weighted-average common shares outstanding 170,567     171,250     171,045 170,036
Earnings (loss) per share, basic (in dollars per share) $ 0.25     $ (0.08)     $ 0.93 $ (0.12)
Diluted                
Net income (loss) $ 43,364 $ 30,077 $ 85,422 $ (14,390) $ 6,613 $ (12,124) $ 158,863 $ (19,901)
Notes - interest expense, net of tax 0     0     742 0
Numerator for diluted EPS $ 43,364     $ (14,390)     $ 159,605 $ (19,901)
Weighted-average effect of dilutive securities:                
Effect of dilutive securities (in shares) 13,528     0     13,960 0
Weighted-average common shares outstanding, assuming dilution (in shares) 184,095     171,250     185,005 170,036
Earnings (loss) per share, diluted (in dollars per share) $ 0.24     $ (0.08)     $ 0.86 $ (0.12)
Outstanding anti-dilutive stock options and RSUs (in shares) 54     9,056     267 7,364
Notes                
Weighted-average effect of dilutive securities:                
Notes (in shares) 0     0     1,599 0
Stock options                
Weighted-average effect of dilutive securities:                
Stock options and RSUs (in shares) 10,113     0     8,971 0
RSUs                
Weighted-average effect of dilutive securities:                
Stock options and RSUs (in shares) 3,415     0     3,390 0
v3.25.3
COMMITMENTS AND CONTINGENCIES (Details)
Sep. 15, 2022
USD ($)
May 09, 2022
USD ($)
Sep. 30, 2025
USD ($)
Feb. 26, 2025
lawsuit
Dec. 31, 2024
USD ($)
Dec. 04, 2024
lawsuit
Sep. 29, 2022
USD ($)
Loss Contingencies [Line Items]              
Litigation liability     $ 0   $ 0    
Pending Litigation              
Loss Contingencies [Line Items]              
Number of pending lawsuits | lawsuit       2      
Appian Corp. v. Pegasystems Inc. & Youyong Zou              
Loss Contingencies [Line Items]              
Outstanding letters of credit             $ 25,000,000
Appian Corp. v. Pegasystems Inc. & Youyong Zou | Judicial Ruling              
Loss Contingencies [Line Items]              
Loss contingency, damages awarded, value $ 2,060,479,287            
Class Action, Case 12999 and Case 11220 | Pending Litigation              
Loss Contingencies [Line Items]              
Percentage of settlement class that opted out of court approved settlement           3.00%  
Number of pending lawsuits | lawsuit           2  
Case 2584CV00541-BLS1 and Case 2584CV00539-BLS1 | Pending Litigation              
Loss Contingencies [Line Items]              
Number of pending lawsuits | lawsuit       2      
Trade Secret Misappropriation | Appian Corp. v. Pegasystems Inc. & Youyong Zou              
Loss Contingencies [Line Items]              
Legal fees, post-judgement interest rate, percentage 6.00%            
Trade Secret Misappropriation | Appian Corp. v. Pegasystems Inc. & Youyong Zou | Judicial Ruling              
Loss Contingencies [Line Items]              
Loss contingency, damages awarded, value   $ 2,036,860,045          
Violation of the Virginia Computer Crimes Act | Appian Corp. v. Pegasystems Inc. & Youyong Zou | Judicial Ruling              
Loss Contingencies [Line Items]              
Loss contingency, damages awarded, value   $ 1.00